entrez_id,symbol,name,CRISPR_depCL_frac,CRISPR_strong_depCL_count,RNAi_depCL_frac,RNAi_strong_depCL_count,CRISPR_min_gene_effect,CRISPR_min_gene_effect_zscore,RNAi_min_gene_effect,RNAi_min_gene_effect_zscore,CRISPR_Mean,CRISPR_Variance,CRISPR_Skewness,RNAi_Mean,RNAi_Variance,RNAi_Skewness,CRISPR_PanDependency,RNAi_PanDependency,CRISPR_bimodal_pval,RNAi_bimodal_pval,CRISPR_LRT,RNAi_LRT,CRISPR_Context,RNAi_Context,CRISPR_ensemble_pearson,CRISPR_top_model,CRISPR_good_models,CRISPR_moderate_models,RNAi_ensemble_pearson,RNAi_top_model,RNAi_good_models,RNAi_moderate_models,BiomarkerID_CRISPR_Genetic_Driver,BiomarkerID_CRISPR_Genetic_Driver_Feature,BiomarkerID_RNAi_Genetic_Driver,BiomarkerID_RNAi_Genetic_Driver_Feature,BiomarkerID_CRISPR_Expression_Addiction,BiomarkerID_CRISPR_Expression_Addiction_Tissue,BiomarkerID_RNAi_Expression_Addiction,BiomarkerID_RNAi_Expression_Addiction_Tissue,BiomarkerID_CRISPR_Synthetic_Lethal,BiomarkerID_CRISPR_Synthetic_Lethal_Oncogene,BiomarkerID_CRISPR_Synthetic_Lethal_TSG,BiomarkerID_RNAi_Synthetic_Lethal,BiomarkerID_RNAi_Synthetic_Lethal_Oncogene,BiomarkerID_RNAi_Synthetic_Lethal_TSG,BiomarkerID_CRISPR_Paralog_Mutation_Driven,BiomarkerID_CRISPR_Paralog_Expression_Driven,BiomarkerID_CRISPR_Paralog,BiomarkerID_RNAi_Paralog_Mutation_Driven,BiomarkerID_RNAi_Paralog_Expression_Driven,BiomarkerID_RNAi_Paralog,BiomarkerID_CYCLOPS,BiomarkerID_Cell_Line_Essential,canSAR_drug_target,canSAR_bioactive_compounds,canSAR_available_structure,canSAR_druggable_structure,canSAR_druggable_by_ligand_based_assessment,canSAR_enzyme,canSAR_cell_membrane,canSAR_cytoplasm,canSAR_extracellular,canSAR_nuclear_membrane,canSAR_nucleus,canSAR_organelle,canSAR_organelle_membrane,canSAR_ligand_druggability_score,canSAR_ligand_druggability_percentile,canSAR_network_druggability_overall,canSAR_network_druggability_cancer,canSAR_network_druggability_other,canSAR_network_druggability_cancer_associated,Broad_isMetabolic,Broad_isTF,Broad_isCellSurface,Broad_RepHub_Compound,Broad_inRepHub,Broad_Cancer Use Conditions,Broad_Integrity_DevPhase,Broad_established_target,Broad_targetID_blacklist,Broad_IUPHAR_druggable
1,A1BG,alpha-1-B glycoprotein,0.001813236627379873,0,0.005484460694698354,0,-0.6556682871664882,-6.232019426863804,-0.725977260345266,-3.5175268727690994,-0.020565758799049216,0.01038556400099549,-0.31596465770926707,-0.041000281326568806,0.037920766183498635,0.19652845215679968,FALSE,FALSE,0.9802198518151938,0.9919681627379658,87.8955167048775,26.5610674793783,brenner_tumor_disease_subtype_I; renal_leiomyoblastoma_disease_subtype_II; CML_disease_subtype_I; malignant_rhabdoid_tumor_disease_subtype_I; engineered_primary_tissue; engineered_blood_disease,bladder_transitional_cell_disease_subtype_II; Colon_primary_tissue; M5_disease_subtype_II; urinary_tract_disease; bladder_carcinoma_disease_subtype_I,0.08868246157836596,DNA_based: [VMO1_(284013)_CN],NA,NA,0.12871968141168483,Core_omics: [PSMB9_(5698)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-3,59,52.91,51.84,34.01,68.39,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
10350,ABCA9,ATP binding cassette subfamily A member 9,0,0,0,0,-0.3585886981480624,-4.758915798575802,-0.541329658531653,-4.486970052544445,0.03698314814173852,0.006909310455529512,0.17522252262015525,0.07817337065823055,0.019062529410242644,-0.003898021355137063,FALSE,FALSE,0.9201545531571123,0.9830201284535278,75.5861681753049,30.3717795102058,M7_disease_subtype_II; breast_adenocarcinoma_disease_subtype_I; ERpos_HER2pos_disease_subtype_II; abdomen_primary_tissue,M7_disease_subtype_II; ERpos_HER2pos_disease_subtype_II; ERneg_HER2pos_disease_subtype_II; AML_disease_subtype_I; breast_disease,0.04957480283825947,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.11570772318975332,Core_omics: [EIF4EBP1_(1978)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,1.45,94,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,TRUE
215,ABCD1,ATP binding cassette subfamily D member 1,0.02917046490428441,6,NA,NA,-1.1054417587196728,-6.879039398300902,NA,NA,-0.10381109172858262,0.021201160421906475,-1.6321652664522248,NA,NA,NA,FALSE,NA,0.9921249936761026,NA,280.710329342633,21.7732063976921,pancreas_disease; pancreas_primary_tissue; NSCLC_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; exocrine_adenocarcinoma_disease_subtype_II,NA,0.22745211296638188,Core_omics: [IQCH_(64799)_MutDam],NA,NA,0.09296713551475143,Related: [SLC39A4_(55630)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,-1.1,67,99.03,68.86,99.34,34.48,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
3730,ANOS1,anosmin 1,0,0,0,0,-0.2483903277291307,-3.6002517971697494,-0.520132910320178,-3.9093971244175294,0.03303607910025148,0.006110319786469629,0.4267295160579781,0.04160526698738,0.02064658855025007,0.061425786312092244,FALSE,FALSE,0.9904387846839776,0.9938039255332285,89.719567356115,7.4872131588221,ovary_disease; ovary_adenocarcinoma_disease_subtype_I,Leukemia_histology_I; blood_disease,0.0565672237228889,Core_omics: [AP2S1_(1175)_RNAseq],NA,NA,0.20893644192778993,Core_omics: [FAXC_(84553)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,0.2,82,79.76,95.62,70.65,65.49,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
673,BRAF,"B-Raf proto-oncogene, serine/threonine kinase",0.0815956482320943,57,0.06179775280898876,25,-1.4124282673225317,-4.82567720244166,-3.4840800346773,-10.711301576142045,-0.12678029382244357,0.07097862852151289,-2.664302225368557,-0.06409687574896349,0.10194441566351328,-3.9046765756544524,FALSE,FALSE,0.9515603274997444,0.9842722525476528,1039.32770010538,764.312086784294,melanoma_disease_subtype_I; Melanoma_histology_II; skin_disease; skin_primary_tissue; amelanotic_disease_subtype_II,melanoma_disease_subtype_I; skin_disease; Melanoma_histology_II; skin_primary_tissue; thyroid_carcinoma_disease_subtype_I,0.7766706804027815,Related: [BRAF_(673)_MutHot],Core_omics: [BRAF_(673)_MutHot] | DNA_based: [BRAF_(673)_MutHot],NA,0.734788942283094,DNA_based: [BRAF_(673)_MutHot],Core_omics: [BRAF_(673)_MutHot] | Related: [BRAF_(673)_MutHot],NA,TRUE,Gain-of-function,TRUE,Gain-of-function,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,1.3,93,98.5,99.3,93.87,97.14,FALSE,FALSE,FALSE,AZ-628|CEP-32496|dabrafenib|GDC-0879|LGX818|LY3009120|PLX-4720|PLX8394|RAF265|regorafenib|Ro-5126766|SB-590885|sorafenib|TAK-632|vemurafenib|ZM-336372,TRUE,34,Discontinued,TRUE,TRUE,TRUE
148304,C1orf74,chromosome 1 open reading frame 74,0.019945602901178604,1,0,0,-0.8655738734635665,-6.134915123419102,-0.649817509938262,-4.533975995628173,-0.14480223879679957,0.013803151565592028,-0.3997572264420005,0.07504551004027132,0.025559564820647338,-0.2406262604754831,FALSE,FALSE,0.9966898147187504,0.8278364298778521,58.7464749815049,9.18290769380326,T-cell_histology_II; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I; Rhabdomyosarcoma_histology_II; peripheral_nervous_system_disease,ERneg_HER2pos_disease_subtype_II; breast_disease; breast_carcinoma_disease_subtype_I; Carcinoma_histology_II; Oligodendroglioma_histology_II; oligodendroglioma_disease_subtype_II,0.292826283342156,Core_omics: [IGLL1_(3543)_RNAseq],NA,NA,0.22383237122226743,Core_omics: [DGAT1_(8694)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-1.9,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
768,CA9,carbonic anhydrase 9,0.0027198549410698096,0,0,0,-0.45425715739662603,-3.747780321670225,-0.46182092152609,-2.859888105729128,-0.08098678275463687,0.009919705804896416,0.00848205187712052,-0.04902180914203627,0.020834324615622356,0.04384856082901287,FALSE,FALSE,0.9962091448122236,0.9927772229338544,58.8833990143389,16.5247054384772,sinonasal_primary_tissue; endocervical_disease_subtype_II; salivary_gland_primary_tissue; cervical_adenocarcinoma_disease_subtype_I,cervical_squamous_disease_subtype_I; upper_aerodigestive_tract_primary_tissue,0.15995928326747494,Core_omics: [MXD1_(4084)_RNAseq],NA,NA,0.22041732676547662,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,1.7,96,90.49,81.4,93.06,65.73,TRUE,FALSE,FALSE,benzthiazide|carzenide|coumarin|curcumin|ellagic-acid|ethoxzolamide|ferulic-acid|gallic-acid|hydrochlorothiazide|hydroflumethiazide|indisulam|mafenide|para-toluenesulfonamide|phenol|saccharin|spermine|U-104|zonisamide|2-aminobenzenesulfonamide,TRUE,14,Discontinued,FALSE,FALSE,FALSE
751071,CSKMT,citrate synthase lysine methyltransferase,0.038984587488667274,0,NA,NA,-0.7950620722504713,-5.376030041539424,NA,NA,-0.18702474785144876,0.012791960353816662,-0.6174720567395637,NA,NA,NA,FALSE,NA,0.9906790487511866,NA,79.3076679303128,NA,clear_cell_disease_subtype_II; hypopharyngeal_disease_subtype_II,NA,0.25519617335927025,Related: [CSKMT_(751071)_CN; cell_line_NNMD_crispr_confounders; cas9_activity_crispr_confounders; CSKMT_(751071)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
51603,EEF1AKNMT,eEF1A lysine and N-terminal methyltransferase,0.0027198549410698096,1,0.0033500837520938024,0,-0.7944600900538109,-7.323490023425464,-0.875704047984431,-4.953241133075238,-0.04325546535231785,0.010521564390672592,-0.6684165034818377,-0.11753331526057613,0.023429072139808754,-0.4310602979570347,FALSE,FALSE,0.9941219496799304,0.9806263418492887,147.023407460951,43.4404932975661,WDLPS_histology_II; WDLPS_disease_subtype_II; Liposarcoma_histology_I; liposarcoma_disease_subtype_I; embryo_carcinoma_disease_subtype_I,engineered_breast_disease; biliary_tract_primary_tissue; bile_duct_disease; cholangiocarcinoma_disease_subtype_I; intrahepatic_disease_subtype_II,0.29742389120364443,Core_omics: [TADA1_(117143)_RNAseq],NA,NA,0.1485223520309599,DNA_based: [RAB21_(23011)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-3,59,12.89,11.64,14.8,21.2,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
8263,F8A1,coagulation factor VIII associated 1,NA,NA,0,0,NA,NA,-0.734438858386688,-4.449966260815689,NA,NA,NA,0.16481114190732213,0.04083640072138678,-0.18839977660741397,NA,FALSE,NA,0.5706078143719748,NA,8.01306674259172,NA,breast_primary_tissue,NA,NA,NA,NA,0.23389408597021677,Core_omics: [KCNMA1_(3778)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,61.36,13.56,48.87,21.57,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6928,HNF1B,HNF1 homeobox B,0.11604714415231188,64,0.05352112676056338,12,-1.500360600883696,-4.701053762518968,-3.12022635380757,-11.449103749901694,-0.21943337525991194,0.07424350682074796,-2.3020681653434045,-0.0327635195458059,0.07272110929871295,-3.731189135443447,FALSE,FALSE,0.9975333579402103,0.9950296178979867,932.602808778786,584.286140673842,kidney_disease; renal_cell_carcinoma_disease_subtype_I; kidney_primary_tissue; clear_cell_disease_subtype_II; biliary_tract_primary_tissue,renal_cell_carcinoma_disease_subtype_I; kidney_disease; kidney_primary_tissue; clear_cell_disease_subtype_II; biliary_tract_primary_tissue; bile_duct_disease; cholangiocarcinoma_disease_subtype_I; intrahepatic_disease_subtype_II,0.7794686176724251,Related: [HNF1B_(6928)_RNAseq],Core_omics: [HNF1B_(6928)_RNAseq],DNA_based: [kidney_Lin; renal_cell_carcinoma_Lin],0.6500352508694796,Core_omics: [HNF1B_(6928)_RNAseq],Related: [HNF1B_(6928)_RNAseq],DNA_based: [renal_cell_carcinoma_Lin],TRUE,Copy Number,TRUE,Copy Number,TRUE,Essential Tissue,TRUE,Essential Tissue,TRUE,NA,VHL (Lineage),TRUE,NA,VHL (Lineage),NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,51.04,60.47,21.59,83.24,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
80853,KDM7A,lysine demethylase 7A,0,0,0,0,-0.3778317603610085,-4.218137558962399,-0.481274734800258,-3.859146194796915,0.007506734271198828,0.0083453261775315,-0.14234143130684576,-0.007802102881618403,0.015052453662334086,-0.5946566768296949,FALSE,FALSE,0.9276157010158943,0.9274824300515752,63.0345899664612,38.4266628680341,plasmacytoma_disease_subtype_II; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; Melanoma_histology_II,autonomic_ganglia_primary_tissue; papillary_disease_subtype_II; Neuroblastoma_histology_I; peripheral_nervous_system_disease; neuroblastoma_disease_subtype_I,0.2914085197757792,Core_omics: [REPIN1_(29803)_RNAseq],NA,NA,0.3044061835871674,Core_omics: [GUCY1A1_(2982)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,Biological Testing,FALSE,FALSE,TRUE
9448,MAP4K4,mitogen-activated protein kinase kinase kinase kinase 4,0.0027198549410698096,0,0.0014124293785310734,0,-0.6123147888729467,-3.439582495927174,-0.754928842330627,-3.7132066543149063,-0.012696743021992167,0.030390505860715827,0.765771235521887,0.029255931694887233,0.04460038125319514,0.18017545599052806,FALSE,FALSE,0.9982201538943233,0.9964024118106544,102.297716196678,16.0922940162817,endometrial_adenocarcinoma_disease_subtype_I; breast_disease; uterus_disease; ERneg_HER2pos_disease_subtype_II; endometrium_primary_tissue,haematopoietic_and_lymphoid_tissue_primary_tissue; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; ATL_histology_II; ATL_disease_subtype_I,0.3919136424814876,Core_omics: [DCBLD2_(131566)_RNAseq],NA,NA,0.3294111936082196,Core_omics: [DCBLD2_(131566)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-0.3,76,63.99,81.47,56.69,84.97,FALSE,FALSE,FALSE,NA,FALSE,1,Preclinical,FALSE,FALSE,TRUE
4199,ME1,malic enzyme 1,0.007252946509519492,0,0.003656307129798903,0,-0.5833215796234223,-4.364526428872084,-0.774134444104892,-3.7150442886643646,-0.15225873372625912,0.009754543018196926,-0.4429779300256448,0.005331403619515239,0.04402163733379772,0.1091330143216032,FALSE,FALSE,0.9946050520287827,0.9588041145572751,65.6377747406259,19.3004632417318,mixed_germ_cell_disease_subtype_I; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I,Osteosarcoma_histology_II; osteosarcoma_disease_subtype_I; breast_adenocarcinoma_disease_subtype_I; Carcinoma_histology_II; breast_carcinoma_disease_subtype_I,0.2714789477716891,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.24297956572455573,Core_omics: [EDA2R_(60401)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,-1.25,66,34.76,3.39,63.97,6.08,TRUE,FALSE,FALSE,coenzyme-i,TRUE,0,NA,FALSE,FALSE,FALSE
4200,ME2,malic enzyme 2,0.008159564823209429,1,0,0,-0.8384496746196783,-6.05854145976184,-0.771735352143004,-4.307043127568798,0.0025917672616685102,0.019270750275096584,-0.29172552520426476,-0.013200570134972082,0.03101648354194196,-0.365629327937111,FALSE,FALSE,1,0.7106564117423314,116.346138327961,15.8845247760725,non_hodgkin_lymphoma_disease_subtype_I; Lymphoma_histology_I; lymphocyte_disease; b_cell_disease_subtype_II; haematopoietic_and_lymphoid_tissue_primary_tissue,engineered_prostate_disease; renal_leiomyoblastoma_disease_subtype_II; prostate_primary_tissue; breast_disease; breast_carcinoma_disease_subtype_I,0.25675862582146664,Core_omics: [PAX5_(5079)_RNAseq],NA,NA,0.01782706389948305,DNA_based: [RNU1_4_(6060)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,-3,59,55.5,55.65,59,20.94,TRUE,FALSE,FALSE,coenzyme-i|malic-acid,TRUE,0,NA,FALSE,FALSE,FALSE
10873,ME3,malic enzyme 3,9.066183136899365e-4,0,0,0,-0.6029477525985261,-5.777767375184064,-0.541434270666411,-3.4004716866000897,0.010463220636006238,0.011271532743240031,-0.6640667077439903,0.034204907474808255,0.028656448301835516,-0.32229838411846906,FALSE,FALSE,0.9960490105462191,0.9587015641349708,106.990318333875,7.34728570385369,uvea_primary_tissue; uveal_melanoma_disease_subtype_I; eye_disease; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,Astrocytoma_histology_II; astrocytoma_disease_subtype_II; Melanoma_histology_II; Fibrosarcoma_histology_II; fibrosarcoma_disease_subtype_I,0.08641401567250948,Related: [ME3_(10873)_CN],NA,NA,0.3034805077866891,Core_omics: [EDA2R_(60401)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,-1.25,66,0,0,0,0,TRUE,FALSE,FALSE,coenzyme-i,TRUE,0,NA,FALSE,FALSE,FALSE
4201,MEA1,male-enhanced antigen 1,0,0,0,0,-0.3983540579901012,-4.268374478646295,-0.573854744226707,-3.5730602987115994,-0.06606592055073238,0.0060604468353108384,0.10405945253503976,-0.056649282242700286,0.02095296629986728,-0.1031710590041891,FALSE,FALSE,0.9914639379573293,0.9901436766526304,59.9305927433024,5.29432867953113,breast_disease; breast_ductal_carcinoma_disease_subtype_I; Splenic_histology_II; splenic_lymphoma_disease_subtype_II; breast_primary_tissue,colorectal_disease; colorectal_adenocarcinoma_disease_subtype_I; Colon_primary_tissue; ERpos_HER2neg_disease_subtype_II; breast_disease,0.12181669822339401,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.18367019515067073,Core_omics: [LRIG1_(26018)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,9.02,5,8.01,5.12,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
64769,MEAF6,MYST/Esa1 associated factor 6,0.3980054397098821,19,0,0,-1.0198528718305715,-4.037433148138465,-0.319882630462647,-2.797260214037092,-0.3681825571469417,0.026052247037043976,-0.1071295635836199,0.06014227731056342,0.018456884220880376,0.28800088544453595,TRUE,FALSE,0.9938023199158735,0.990465495360987,27.8847419751874,7.10767494526664,ALL_disease_subtype_I; Leukemia_histology_I; blood_disease; ERpos_HER2neg_disease_subtype_II; AML_disease_subtype_I,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; merkel_cell_carcinoma_disease_subtype_I; engineered_breast_disease,0.195866482542241,Core_omics: [SYNE3_(161176)_RNAseq],NA,NA,0.26124271572137375,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,32.42,49.1,19.39,67.72,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
2122,MECOM,MDS1 and EVI1 complex locus,0.019945602901178604,5,0.008438818565400843,0,-0.94480897277163,-6.656497441257058,-0.919222402449652,-5.472238581076735,-0.02404258675305309,0.01913407067873437,-1.6651419075000187,0.006902040213380739,0.028642349876197987,-1.1691683670075796,FALSE,FALSE,0.9887654819301195,0.9925228572240083,380.19903803763,167.029250053108,ovary_disease; ovary_adenocarcinoma_disease_subtype_I; endometrial_adenocarcinoma_disease_subtype_I; endometrium_primary_tissue; uterus_disease,mixed_endometrioid_clear_cell_disease_subtype_II; clear_cell_disease_subtype_II; ovary_disease; ovary_adenocarcinoma_disease_subtype_I; M4_disease_subtype_II,0.4992544158154261,Core_omics: [WNT7A_(7476)_RNAseq; MECOM_(2122)_RNAseq],NA,Related: [MECOM_(2122)_RNAseq],0.36595529807000776,Core_omics: [MECOM_(2122)_RNAseq],NA,NA,NA,NA,NA,NA,TRUE,Essential Tissue,TRUE,Essential Tissue,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,62.14,89.22,47.13,98.43,FALSE,TRUE,FALSE,NA,FALSE,1,Preclinical,FALSE,FALSE,FALSE
4204,MECP2,methyl-CpG binding protein 2,0,0,0.028169014084507043,2,-0.4269479292438694,-6.268105229964222,-1.18699022182321,-4.33140061215372,0.06725571906250928,0.006216405507197544,-0.1875942248775687,-0.0912266734796247,0.06399956042121782,-0.3421277185918073,FALSE,FALSE,0.9619838897335717,0.9861057475821641,137.297282943372,12.3926082549026,gallbladder_adenocarcinoma_disease_subtype_I; mixed_germ_cell_disease_subtype_I; bile_duct_disease; thyroid_sarcoma_disease_subtype_I,pancreas_primary_tissue,0.0735882909002988,Core_omics: [GAGE2E_(729428)_RNAseq],NA,NA,0.2380359689338154,Core_omics: [MOSMO_(730094)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,-3,59,56.35,80.89,55.92,95.5,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51102,MECR,mitochondrial trans-2-enoyl-CoA reductase,0.04623753399818677,1,0.026685393258426966,0,-0.8572679184750414,-5.688561408393162,-0.896081391059466,-3.611686164965503,-0.1575975197768868,0.015128020327848612,-1.004374431644466,-0.18855180491705953,0.0383768389021776,-0.2177768108986763,FALSE,FALSE,0.9950120924977333,0.9682330922921604,156.613432430083,18.7802989915593,rhabdomyosarcoma_disease_subtype_I; embryo_carcinoma_disease_subtype_I; Rhabdomyosarcoma_histology_II; soft_tissue_disease; Sarcoma_histology_I,endometrial_stromal_sarcoma_disease_subtype_I; Astrocytoma_histology_II; astrocytoma_disease_subtype_II; clear_cell_carcinoma_disease_subtype_I,0.30436713718081265,Core_omics: [UQCRC1_(7384)_RNAseq],NA,NA,0.1840540176507164,Core_omics: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,40.93,52.28,16.82,80.77,TRUE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
5469,MED1,mediator complex subunit 1,0.7234814143245694,464,0.2380281690140845,72,-1.9211331245607848,-2.8787286619578625,-2.14859373078799,-4.686786708327133,-0.7084135778931371,0.17746768800941146,-0.3355427525235993,-0.3319120740413227,0.1502475098820504,-0.9574199691702808,TRUE,FALSE,0.9137733870091926,0.9909210666193331,40.3757966733529,150.783960232898,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Leukemia_histology_I; blood_disease; Melanoma_histology_II,0.5072076322499528,Core_omics: [MED31_(51003)_RNAseq],NA,Related: [MED31_(51003)_RNAseq],0.4656463126354779,Core_omics: [TMC6_(11322)_RNAseq],NA,Related: [MED10_(84246)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,92.26,96.6,74.71,97.51,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
29079,MED4,mediator complex subunit 4,0.9918404351767905,978,0.2084507042253521,15,-2.1057882839748725,-3.078734629668811,-1.20309783159671,-3.811172356330469,-1.1770504019358583,0.0910000869137652,0.05986263509240126,-0.42677845915754153,0.041491933013681245,-0.5178678392053301,TRUE,FALSE,0.43574056726831056,0.9937721076930197,0.469297093584998,32.4067425491362,NA,NSCLC_disease_subtype_I; lung_disease; lung_primary_tissue; NSCLC_adenocarcinoma_disease_subtype_II; exocrine_adenocarcinoma_disease_subtype_II,0.4326522797716067,Related: [cas9_activity_crispr_confounders],NA,Core_omics: [cas9_activity_crispr_confounders],0.2958527170448232,Core_omics: [RSC1A1_(6248)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,12.37,60.1,60.56,71.71,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
10001,MED6,mediator complex subunit 6,0.9981867633726201,1090,0.1676056338028169,8,-2.644924796125836,-3.7129956407204903,-1.08312940868004,-3.10811588546137,-1.5690262701323474,0.08396412110547048,0.2131974204545138,-0.3361318935499663,0.05776222425143504,-0.14254405289917743,TRUE,FALSE,0.9930305448387916,0.9939793185731558,38.5099669484957,8.68713438033348,NA,NA,0.24253976452022868,Core_omics: [cas9_activity_crispr_confounders],NA,NA,0.19622353467131123,Core_omics: [ANXA8_(653145)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,63.4,85.92,47.52,92,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9443,MED7,mediator complex subunit 7,0.8159564823209429,230,0.4251412429378531,83,-1.482354708156988,-3.813462940433633,-1.84243946765942,-4.387169477167174,-0.6106181462952052,0.052255434367551194,-0.23378903112661356,-0.5424156017258485,0.08780794779883917,-0.6913474986034444,TRUE,TRUE,0.9925213543948148,0.955702006848622,17.7235529954537,55.7440767813433,glioma_disease_subtype_I,haematopoietic_and_lymphoid_tissue_primary_tissue,0.23812462942531035,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.4509701406350016,Core_omics: [MED7_(9443)_RNAseq],NA,Related: [MED7_(9443)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-1.15,67,69.16,88.83,37.47,95.98,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
112950,MED8,mediator complex subunit 8,0.9945602901178604,1050,0.5449438202247191,139,-2.142818354350688,-2.841954891774848,-1.85423000737385,-4.003595158745071,-1.3649714721678088,0.07491242738637767,0.8375744273752007,-0.6443692157988732,0.09132096548190437,-0.46491212824796535,TRUE,TRUE,0.9665437994655348,0.9937425735572364,138.216659905853,25.6106905508794,NA,Adenocarcinoma_histology_II; colorectal_adenocarcinoma_disease_subtype_I; colorectal_disease; large_intestine_primary_tissue; skin_disease,0.2587500380328423,DNA_based: [cell_line_NNMD_crispr_confounders],NA,NA,0.3125623278291641,Core_omics: [MED8_(112950)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,53.57,76.25,25.46,86.05,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
55090,MED9,mediator complex subunit 9,0.9301903898458749,730,0.12253521126760564,13,-2.082668593348433,-3.5607372732673293,-2.18288000384993,-7.656509570189928,-0.9089046959242423,0.1086629855693485,-0.017335529729525123,-0.29274729916867565,0.06094287439069992,-1.0510232542402698,TRUE,FALSE,0.9605563151287372,0.952941768491613,12.0768779847269,70.7319856570961,NA,AML_disease_subtype_I; Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; exocrine_disease_subtype_I,0.27775541381154706,DNA_based: [MIR8071_1_(102465871)_CN],NA,NA,0.4073652857723859,Related: [UBB_(7314)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,35.78,66.05,26.78,83.42,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84246,MED10,mediator complex subunit 10,0.7370806890299184,289,0.018148820326678767,0,-1.5651979524319015,-3.4626852347370694,-0.765504387803631,-3.409441375930958,-0.5966428936653037,0.0782388750614759,-0.33309660037872507,-0.17630654683552377,0.02986454062926467,-0.13653753425110268,TRUE,FALSE,0.9907120651266617,0.9941779722175584,20.6270962542652,6.98662891102902,haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease; b_cell_disease_subtype_II; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,M5_disease_subtype_II; AML_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease,0.48299799218231504,Core_omics: [ICE1_(23379)_CN],NA,DNA_based: [Haematopoietic_and_Lymphoid_Lin] | Related: [MED10_(84246)_CN],0.2591931615311544,Core_omics: [CYB5D2_(124936)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,53.69,67.64,20.89,76.34,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
400569,MED11,mediator complex subunit 11,1,1099,0.6135770234986945,127,-2.8329458912956014,-3.6769255786489263,-3.07522294457588,-5.8119862138625,-1.7744318899846632,0.08287499864484281,0.9151102784736077,-0.7322800429569913,0.16250781785766436,-0.9204738334059744,TRUE,FALSE,0.9921323193391852,0.9742197854748169,194.951948796025,48.0360426381952,NA,exocrine_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; pancreas_disease,0.13645198815545245,Related: [MED11_(400569)_RNAseq],NA,NA,0.5195476875370348,Related: [MED11_(400569)_RNAseq],NA,Core_omics: [MED11_(400569)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,21.72,60.6,36.35,62.78,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9968,MED12,mediator complex subunit 12,0.5651777575205105,220,0.3732394366197183,101,-1.6432547302794247,-3.3751617873336746,-2.03921200585556,-3.8596573973338146,-0.451542350268515,0.12466763222495122,0.21180610037415593,-0.47190431998089605,0.16489633922732175,0.13284486419958358,FALSE,FALSE,0.9182107854535384,0.6369840647162118,9.87278078939971,31.2013901099798,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; upper_aerodigestive_disease; b_cell_disease_subtype_II,Adenocarcinoma_histology_II; upper_aerodigestive_disease; upper_aerodigestive_squamous_disease_subtype_I; colorectal_disease; colorectal_adenocarcinoma_disease_subtype_I,0.5073357823880296,Core_omics: [C1QL1_(10882)_RNAseq],NA,Related: [APLP1_(333)_RNAseq],0.4992243227959532,Core_omics: [SYDE1_(85360)_RNAseq],NA,Related: [QKI_(9444)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,MED12L,TRUE,NA,MED12L,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,70.49,89.25,25.78,97.83,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
116931,MED12L,mediator complex subunit 12L,0,0,0.0014084507042253522,0,-0.43154456571580935,-6.189361301605488,-0.991485565153594,-5.853921432988027,0.08171856326228032,0.006876832779748568,-0.2727754746776332,0.052143317043099595,0.03178325706260522,0.029133064724035127,FALSE,FALSE,0.9973314731936712,0.9944597312855797,87.406055611018,65.3113078444017,NA,pancreas_primary_tissue; exocrine_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; pancreas_disease; papillary_disease_subtype_II,0.10782687661583219,Core_omics: [SULT1B1_(27284)_RNAseq],NA,NA,0.20699013905636046,Core_omics: [HS3ST1_(9957)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,22.56,29.49,3.74,49.88,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9969,MED13,mediator complex subunit 13,0.0371713508612874,2,0.002824858757062147,0,-1.0514120625831167,-5.4902021717621805,-0.907383069589502,-4.897580660342799,-0.03758894767686331,0.034099475825932535,-0.694165840102537,0.021073040721678413,0.035938468244944566,-0.012872058667938533,FALSE,FALSE,0.9988341545720787,0.9922504407087763,83.2182618647291,36.8837787254004,b_cell_burkitt_disease_subtype_II; non_hodgkin_lymphoma_disease_subtype_I; Lymphoma_histology_I; lymphocyte_disease; haematopoietic_and_lymphoid_tissue_primary_tissue,cervical_squamous_disease_subtype_I; M5_disease_subtype_II; bone_marrow_primary_tissue; AML_disease_subtype_I; ERpos_HER2neg_disease_subtype_II,0.3688600040064805,Core_omics: [P4HA3_(283208)_RNAseq],NA,NA,0.17414732905165412,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.05,79,58.19,66.56,54.51,85.58,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
23389,MED13L,mediator complex subunit 13L,0.04623753399818677,2,0,0,-0.9320204656118352,-5.6331779977069685,-0.583062501182107,-3.9362205435105473,-0.12410324812669633,0.02056964413517374,-1.144992275541061,-0.05447545300519327,0.018033257652854587,-0.044514352586873744,FALSE,FALSE,0.998784932923379,0.8742224562770387,195.758157183838,44.6612951103812,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,Meningioma_histology_II; meningioma_disease_subtype_I; abdomen_primary_tissue; papillary_disease_subtype_II,0.472381600978054,Core_omics: [NRROS_(375387)_RNAseq],NA,Related: [blood_Lin],0.2533907209619899,Core_omics: [IRAG2_(4033)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,28.57,23.6,16.58,54.99,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9282,MED14,mediator complex subunit 14,0.9972652689152234,1068,0.679324894514768,298,-2.3809039943129173,-3.3711241727873515,-2.9578614270305,-5.0831778720896255,-1.420443247237207,0.08117265319042936,0.12400094900446094,-0.8336790541078418,0.17462764104016368,-0.5100512185835787,TRUE,TRUE,0.9911559447537801,0.9642179380862117,18.6886192503668,21.3418634748522,NA,exocrine_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; oesophagus_primary_tissue; pancreas_disease,0.23204901422543303,Core_omics: [EIF2S3_(1968)_RNAseq],NA,NA,0.5517293362356737,Related: [MED14_(9282)_RNAseq; MED14_(9282)_CN],NA,Core_omics: [MED14_(9282)_RNAseq] | DNA_based: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-1.1,67,73.77,95.3,47.5,96.39,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
51586,MED15,mediator complex subunit 15,0.17135086128739802,13,0.00847457627118644,1,-1.2488403669278572,-5.175956411183608,-0.888679949674832,-4.274375341892682,-0.23759580996975777,0.038170792201295864,-0.6135556900278998,-0.09254947981916739,0.034691508106173566,-0.15983933087521385,FALSE,FALSE,0.8661562059998466,0.9904204283938527,64.348914673547,36.8090427005371,haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease; non_hodgkin_lymphoma_disease_subtype_I; ALL_disease_subtype_I,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; uvea_primary_tissue; eye_disease; uveal_melanoma_disease_subtype_I,0.4005007782237687,Core_omics: [SDC4_(6385)_RNAseq],NA,NA,0.32682303118701156,Core_omics: [NMT2_(9397)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,53.59,83.57,29.61,93.36,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
10025,MED16,mediator complex subunit 16,0.185856754306437,35,0.007042253521126761,0,-1.1254462402348762,-3.6854236193059715,-0.858652933651929,-4.360943879743176,-0.1939217971772241,0.06388717441862175,-0.6597981970751704,-0.07187707726167135,0.03254925502278053,-0.01860851347594397,FALSE,FALSE,0.986320074307484,0.9846781504674719,79.1647167325731,27.3416599097836,haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,Leukemia_histology_I; blood_disease; cervical_squamous_disease_subtype_I; AML_disease_subtype_I; b_cell_disease_subtype_II,0.39402612785271907,Core_omics: [RASSF5_(83593)_RNAseq],NA,NA,0.3627563308536988,Core_omics: [RHOB_(388)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-1.25,66,60.78,75.89,45.04,87.74,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9440,MED17,mediator complex subunit 17,0.9909338168631007,961,0.014124293785310734,0,-1.7514171468212842,-2.9350474528427988,-0.845773502039281,-4.0261073668337115,-1.0650570028950197,0.05468571048954708,0.09323256799322713,-0.07205794808383638,0.03693107508824874,-0.3893226879031741,TRUE,FALSE,0.843236571557836,0.9587532311270828,1.66989413823195,29.4126357033833,NA,Glioma_histology_II,0.20785340392419618,Core_omics: [RAB27A_(5873)_RNAseq],NA,NA,0.06509740741594297,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,60.57,87.79,47.43,94.45,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
54797,MED18,mediator complex subunit 18,0.985494106980961,905,0,0,-2.198352629500019,-4.226936821043764,-0.603323889297599,-4.253143777385924,-1.0407012621777607,0.07500739193030205,0.3358275513279833,0.01818181936073993,0.021353551443455198,-0.3258974259518704,TRUE,FALSE,0.9953353721924248,0.8079277202674329,39.3011270148669,38.6428835592609,NA,Neuroblastoma_histology_I; peripheral_nervous_system_disease; neuroblastoma_disease_subtype_I; fibroblast_primary_tissue; Fibroblast_histology_I; fibroblast_disease; fibroblast_soft_tissue_disease_subtype_I,0.1824916253399485,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.10495582004959887,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,69.43,80.65,41.42,86.37,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
219541,MED19,mediator complex subunit 19,0.5757026291931097,175,0.16901408450704225,21,-1.3498729188346534,-2.8979499225368417,-1.37230465436493,-3.9146425046759523,-0.4569451397767943,0.09494036899392312,0.13977775063257156,-0.32338002689719647,0.07179667796092859,-0.27181240094229436,FALSE,FALSE,0.9565379151981052,0.99186953334125,3.90816720483053,24.0302588830602,haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease; AML_disease_subtype_I; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,0.4290539447347369,Core_omics: [AXL_(558)_RNAseq],NA,NA,0.5302609000858635,Core_omics: [RILPL1_(353116)_RNAseq],NA,DNA_based: [Haematopoietic_and_Lymphoid_Lin] | Related: [Haematopoietic_and_Lymphoid_Lin],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,40.19,60.46,22.41,81.09,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
9477,MED20,mediator complex subunit 20,0.9954669084315503,1038,0.18361581920903955,21,-2.0757294816413236,-2.8958004784511666,-1.61172546890424,-4.703610564834687,-1.2703311873099403,0.07735424292416603,0.1423980720339664,-0.33007443105089573,0.07424665164565056,-0.6830773384222458,TRUE,FALSE,1,0.2069910865184128,11.6413746077765,47.0743356878751,NA,Colon_primary_tissue,0.24231873236578844,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.3432692504022369,Related: [MED20_(9477)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,0.2,82,55.53,65.59,34.02,86.42,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9412,MED21,mediator complex subunit 21,0.9927470534904805,891,0.04647887323943662,6,-2.0151618841983647,-4.441427955461697,-1.76981473259592,-7.435278862940549,-0.992639251161464,0.05300302003405184,-0.16711234735790156,-0.28448597246928087,0.039907144861755776,-1.5773035505839543,TRUE,FALSE,0.8793561941174098,0.990907669947532,7.34746381431012,103.458646666232,NA,CML_disease_subtype_I; blast_crisis_disease_subtype_II,0.28916040570569784,Core_omics: [MGLL_(11343)_RNAseq],NA,NA,0.09510297790314955,Core_omics: [ADGRG1_(9289)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,75.42,92.26,38.91,97.16,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
6837,MED22,mediator complex subunit 22,0.9900271985494107,1028,0.010050251256281407,0,-2.1364809599258163,-3.3390874183062045,-0.639019747255545,-3.1669741639181677,-1.2334884992415565,0.0731328789594944,0.7236063255642742,-0.11152116886613823,0.027743007944500273,-0.5138993885717025,TRUE,FALSE,0.7380013904548764,0.9861271399854138,103.796620434535,27.6433068234781,NA,engineered_breast_disease; Adenocarcinoma_histology_II,0.13474160674713662,Core_omics: [DHRS4L2_(317749)_RNAseq],NA,NA,0.22338801673944148,Related: [MED22_(6837)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,RAB35 (new),NA,TRUE,RAB35 (new),NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,39.91,65.33,43.86,74.16,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9439,MED23,mediator complex subunit 23,0.21396192203082504,48,0.015536723163841809,1,-1.3780339756126958,-4.162115162223338,-1.09608352267257,-5.375120785444696,-0.20239751927868055,0.0797843855718653,-0.635149165811698,-0.15668306209334004,0.0305439416872214,-0.6670764771729164,FALSE,FALSE,0.9954145750438578,0.8342555006947499,87.5971410009064,57.4846782251441,haematopoietic_and_lymphoid_tissue_primary_tissue; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; Leukemia_histology_I; blood_disease,Lymphoma_histology_I; lymphocyte_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; Colon_primary_tissue; ATL_histology_II; ATL_disease_subtype_I,0.4382502274409059,Core_omics: [TMEM132A_(54972)_RNAseq],NA,NA,0.39974494121838083,Core_omics: [LOXL2_(4017)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,0.35,83,44.87,83.03,37.24,92.03,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9862,MED24,mediator complex subunit 24,0.4197642792384406,115,0.04507042253521127,5,-1.4332194767126092,-3.6374627222230522,-1.09344260994427,-4.152759858487398,-0.3705320588368402,0.08535205357432372,-0.348964499919551,-0.18862833590303515,0.047472844056583606,-0.644784787273366,FALSE,FALSE,0.9423821365594792,0.9909586750760428,23.2975076227522,41.3973984692972,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; b_cell_disease_subtype_II,haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Leukemia_histology_I; blood_disease; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,0.5085000386641007,Core_omics: [FERMT2_(10979)_RNAseq],NA,Related: [Haematopoietic_and_Lymphoid_Lin],0.35199004059152184,Core_omics: [TMEM132A_(54972)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,51.64,88.96,27.64,94.42,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
81857,MED25,mediator complex subunit 25,0.20670897552130554,29,0.0014124293785310734,0,-1.538956239230946,-5.946714374442564,-0.631632203670705,-3.28068970177858,-0.2573546825526534,0.04644638240765229,-0.6320203834592508,-0.139059757562152,0.0225429069219857,0.25388649264174806,FALSE,FALSE,0.9965764770899141,0.9900934569170656,77.5140507084885,28.9755649914081,pancreas_disease; exocrine_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; AML_disease_subtype_I,ATL_histology_II; ATL_disease_subtype_I; Synovial_histology_II; synovial_sarcoma_disease_subtype_I; endometrial_stromal_sarcoma_disease_subtype_I,0.2870798183365229,Core_omics: [PHACTR3_(116154)_RNAseq],NA,NA,0.23027858565794804,Core_omics: [ITGA5_(3678)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,68.45,91.45,28.63,95.19,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9441,MED26,mediator complex subunit 26,0.8948322756119673,425,0.09985935302390998,8,-1.5577059851562165,-3.2072978453349896,-1.29751730183845,-3.893938456756326,-0.7167117459672079,0.06875550191503961,-0.2605001804342409,-0.25803458017617914,0.07126173357893933,-0.2543552401201342,TRUE,FALSE,0.9930204722803849,0.8557654335050353,15.4999852443621,7.84639702654049,NA,NSCLC_disease_subtype_I; skin_disease; melanoma_disease_subtype_I,0.24692091906168992,Core_omics: [AHR_(196)_RNAseq],NA,NA,0.19651796611119732,Core_omics: [C2CD4D_(100191040)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,45.24,54.05,34.96,85.94,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9442,MED27,mediator complex subunit 27,0.956482320942883,621,0.009859154929577466,0,-1.9342160058586435,-4.8226461988246445,-0.747404474902873,-3.6862945344903064,-0.8100388797737278,0.054337378779051766,-0.17619258443727004,-0.11750767406284773,0.029198378938630417,-0.501650778904379,TRUE,FALSE,0.9939539768133496,0.9867419317859466,6.35431421215776,41.3013236609369,NA,M2_disease_subtype_II; M5_disease_subtype_II; exocrine_adenosquamous_disease_subtype_II; engineered_kidney_disease; AML_disease_subtype_I,0.3825473114967371,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.16310149957886494,Core_omics: [RABL6_(55684)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,44.38,63.35,36.28,85.46,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
80306,MED28,mediator complex subunit 28,0.99909338168631,1094,0.7754237288135594,317,-2.3805675513983484,-3.737045097774742,-2.29716088625693,-3.9774659097424534,-1.4898191285837346,0.056813748759170786,0.04327827209967856,-0.8767858070289305,0.1275243608983734,-0.38965031594934324,TRUE,TRUE,0.996070773325503,0.9917781365000431,26.6820830252727,23.1172319669745,NA,skin_disease; melanoma_disease_subtype_I; Melanoma_histology_II; skin_primary_tissue,0.2628577860944178,Related: [MED30_(90390)_RNAseq],NA,NA,0.4025602520688794,Related: [MED28_(80306)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.95,69,61.69,89.24,38.73,94.79,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
55588,MED29,mediator complex subunit 29,0.9365367180417045,457,0.005625879043600563,0,-1.5457835172330368,-3.766583539939649,-0.882377575987717,-4.431009598546495,-0.7373282762115501,0.046069845226989245,-0.21967486278207277,-0.12420632301603407,0.029277180181887377,-0.3680430378107036,TRUE,FALSE,0.9906177702616612,0.9984322866680402,12.8308799375664,35.6788396736491,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,biliary_tract_primary_tissue; bile_duct_disease; cholangiocarcinoma_disease_subtype_I; intrahepatic_disease_subtype_II; med_group_3_disease_subtype_II,0.20836035195855393,Core_omics: [INPP5D_(3635)_RNAseq],NA,NA,0.1844184278027315,Core_omics: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0.6,86,44.31,50.96,34.9,81.45,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
90390,MED30,mediator complex subunit 30,0.9981867633726201,1092,0.3064971751412429,45,-2.862564756046259,-4.405103870896422,-1.82755504958541,-5.680893697742039,-1.8196642235829628,0.05604972312498449,1.8084550165331665,-0.4874305796285969,0.05564894675566818,-0.8948441003963364,TRUE,TRUE,1,0.9946304935554451,448.506312351144,97.6169411073176,NA,exocrine_adenocarcinoma_disease_subtype_II; exocrine_disease_subtype_I; pancreas_disease; Melanoma_histology_II; melanoma_disease_subtype_I,0.09402011663025422,Core_omics: [C6orf58_(352999)_RNAseq],NA,NA,0.48207269236150374,Related: [MED30_(90390)_RNAseq],NA,Core_omics: [MED30_(90390)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,34.33,59.43,24.47,80.16,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
51003,MED31,mediator complex subunit 31,0.9954669084315503,1043,0,0,-1.97785647656076,-3.7201545557547906,-1.00900909752812,-6.577719576514782,-1.1623971270586528,0.04804881333544935,0.26541857660166096,0.0050826231577528694,0.02376860891852178,-0.7906443058450179,TRUE,FALSE,0.9926114837966188,0.9549161576169161,51.2196015036419,97.8054491420515,NA,Oligodendroglioma_histology_II; oligodendroglioma_disease_subtype_II,0.29580449421034133,Core_omics: [C1QBP_(708)_RNAseq],NA,NA,0.12416816676228166,Core_omics: [CCL5_(6352)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,36.43,69.99,26.29,77.8,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84935,MEDAG,mesenteric estrogen dependent adipogenesis,0,0,0,0,-0.3196190514411559,-3.6861625860716547,-0.591670104333268,-4.180633201551713,0.010680796906431082,0.008029116787685635,0.2198960332064622,0.023368764535904037,0.02164317620834564,-0.18736091850795378,FALSE,FALSE,0.9925542631804454,0.8426437673100036,58.2850879947232,12.6861583036951,M5_disease_subtype_II; small_intestine_primary_tissue,ERneg_HER2pos_disease_subtype_II; breast_primary_tissue; ERpos_HER2pos_disease_subtype_II; breast_disease; engineered_breast_disease,0.14265958686936656,Core_omics: [TNFSF13_(8741)_RNAseq],NA,NA,0.10986522385116806,Core_omics: [NNMT_(4837)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-1.95,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4205,MEF2A,myocyte enhancer factor 2A,0,0,0,0,-0.4164562710606141,-4.125851427583385,-0.609626488362817,-3.0913582107361512,0.007957235745922605,0.01058159715047037,-0.39206392110149363,-0.002824067347961716,0.03852972826640233,0.23448701340928838,FALSE,FALSE,0.9977305495363693,0.9795419439888604,70.5871339936264,22.1843230949486,Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,ATL_histology_II; ATL_disease_subtype_I; merkel_cell_carcinoma_disease_subtype_I; Ewing_sarcoma_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue,0.2603948918361421,Core_omics: [CCN1_(3491)_RNAseq],NA,NA,0.3111820593520701,Core_omics: [TP53_(7157)_MutHot],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,77.31,96.58,55.5,97.92,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
100271849,MEF2B,myocyte enhancer factor 2B,0.030825022665457842,18,0.004225352112676056,1,-2.235397983374236,-10.284296475682636,-1.68095213492562,-10.018119225261366,-0.17065811569928738,0.040307096133222683,-4.988337322393038,0.10688834151526644,0.03184821812461495,-1.7099386621726806,FALSE,FALSE,0.9826197989952483,0.9907901178883769,960.187193188458,192.774184389164,non_hodgkin_lymphoma_disease_subtype_I; Lymphoma_histology_I; lymphocyte_disease; b_cell_burkitt_disease_subtype_II; DLBCL_disease_subtype_II,non_hodgkin_lymphoma_disease_subtype_I; Lymphoma_histology_I; lymphocyte_disease; DLBCL_disease_subtype_II,0.7185750918511378,Related: [MEF2B_(4207)_RNAseq],Core_omics: [MEF2B_(4207)_RNAseq],DNA_based: [non_hodgkin_lymphoma_Lin; KIR2DS4_(3809)_CN],0.2882090815281914,Related: [MEF2B_(4207)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,BCL2 (new),NA,TRUE,BCL2 (new),NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,64.08,66.62,36.09,62.69,FALSE,TRUE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
4208,MEF2C,myocyte enhancer factor 2C,0.03535811423390753,18,0.008450704225352112,2,-1.5853361136322992,-8.447169088527982,-1.05841039759839,-6.1752187124288485,-0.05247088825874494,0.032929532765187626,-4.340337596676236,0.05897964935611877,0.03274197777140709,-1.0720523803125548,FALSE,FALSE,0.9919334181756955,0.9919475551146631,1342.37103436995,128.564412583506,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease,b_cell_disease_subtype_II; ALL_disease_subtype_I; Leukemia_histology_I; blood_disease; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,0.6373146870936147,Core_omics: [MEF2C_(4208)_RNAseq],Related: [MEF2C_(4208)_RNAseq],DNA_based: [plasma_cell_Lin; multiple_myeloma_Lin],0.2393720635636354,Core_omics: [MEF2C_(4208)_RNAseq],NA,NA,NA,NA,NA,NA,TRUE,Essential Tissue,TRUE,Essential Tissue,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,80.38,93.87,62.06,96.5,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4209,MEF2D,myocyte enhancer factor 2D,0.019038984587488667,6,0.007042253521126761,0,-1.0264773371307252,-7.276845344361048,-1.01979164469076,-4.988725463399029,-0.08918956916713727,0.016590505117141146,-1.7312650500765452,0.0645203914873001,0.04724211665375436,-0.23484362257504604,FALSE,FALSE,0.9837208925667881,0.9911922482894241,285.64344722032,23.5676340544055,M4_disease_subtype_II; haematopoietic_and_lymphoid_tissue_primary_tissue; AML_disease_subtype_I; Leukemia_histology_I; blood_disease,AML_disease_subtype_I; Leukemia_histology_I; blood_disease; haematopoietic_and_lymphoid_tissue_primary_tissue; M4_disease_subtype_II,0.3961109260741693,Related: [MEF2D_(4209)_RNAseq],NA,NA,0.2677311097655252,Core_omics: [RPL18A_(6142)_RNAseq],NA,NA,NA,NA,NA,NA,TRUE,Essential Tissue,TRUE,Essential Tissue,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,0.05,80,76.44,90.39,80.08,92.45,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4210,MEFV,"MEFV innate immuity regulator, pyrin",0,0,0,0,-0.4209366543636768,-5.158028359971575,-0.466414530722141,-3.780720788498775,0.002326803294173129,0.006733705204802801,-0.1336550899033228,0.029524830712128025,0.017207110450718932,0.5907780694238183,FALSE,FALSE,0.991996581568758,0.9905451939528888,91.6371217652049,36.6986812043849,pericardial_effusion_primary_tissue; uterus_disease; Choriocarcinoma_histology_II; choriocarcinoma_disease_subtype_I; endometrial_adenocarcinoma_disease_subtype_I,spleen_primary_tissue,0.16910779774297705,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.2328009770943323,Core_omics: [PLEKHG3_(26030)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.65,72,10.42,13.77,12.4,13.51,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
1953,MEGF6,multiple EGF like domains 6,0,0,0.05850091407678245,0,-0.4594432222225697,-4.928667139802144,-1.04270635240286,-3.7965293530283,-0.022671862699771905,0.007853248272938863,-0.25459526654298364,-0.32881214301398004,0.035358529452060146,-0.10537943609882816,FALSE,FALSE,0.9962802530711595,0.8170694879517746,47.0178937760438,14.2680956311921,extrahepatic_disease_subtype_II; cholangiocarcinoma_disease_subtype_I; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,breast_ductal_carcinoma_disease_subtype_I; ERpos_HER2pos_disease_subtype_II; breast_disease,0.05378309680963339,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.17683004181957376,Core_omics: [RPS18_(6222)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,-1.85,60,72.21,56.41,94.75,60.37,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
1954,MEGF8,multiple EGF like domains 8,0.001813236627379873,0,0.002824858757062147,0,-0.4575539626632564,-3.9375960204600142,-0.875702527582823,-5.182988811692426,0.0026872049195663613,0.013661821624705852,-0.007788266870228321,-0.0883274479654373,0.023078245441917843,-0.46952188698572694,FALSE,FALSE,0.9994009507822984,0.9927151073084292,64.375386056641,65.1609495132222,signet_ring_cell_disease_subtype_II; Rhabdoid_histology_I; med_group_3_disease_subtype_II; PNET_disease_subtype_I; ATRT_disease_subtype_I,uvea_primary_tissue; eye_disease; uveal_melanoma_disease_subtype_I; endometrial_adenosquamous_disease_subtype_I; Somatostatinoma_histology_II; endocrine_disease_subtype_I; somatostatinoma_disease_subtype_II,0.14714620795144787,DNA_based: [C4A_(720)_CN],NA,NA,7.661457157545435e-4,Core_omics: [DIPK2A_(205428)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,0.05,80,20.64,21.9,15.9,33.19,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
1955,MEGF9,multiple EGF like domains 9,0,0,0,0,-0.36937794235494936,-4.099068063334415,-0.704533348983539,-3.7738637666203507,0.05096105722493678,0.010515480278430071,-0.12230190494300115,-0.13079864771598979,0.023112653018853967,0.04572399833097447,FALSE,FALSE,0.8828439697380654,0.9817484514642224,145.448502059573,12.7588726127833,Synovial_histology_II; synovial_sarcoma_disease_subtype_I; t_cell_disease_subtype_II; soft_tissue_disease; soft_tissue_primary_tissue,large_intestine_primary_tissue; Adenocarcinoma_histology_II; colorectal_adenocarcinoma_disease_subtype_I; colorectal_disease,0.13995443238515085,Core_omics: [MPZL3_(196264)_RNAseq],NA,NA,0.16922272380935643,Core_omics: [KCNJ14_(3770)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84466,MEGF10,multiple EGF like domains 10,0.001813236627379873,0,0,0,-0.5739288274169712,-6.383530604454827,-0.381170000009302,-2.8306363528235434,0.015983385045220948,0.008539901951586916,-0.3761606392676887,0.15050480693118723,0.03527962858823765,0.19914075085604227,FALSE,FALSE,0.9947798202173134,0.9720018667083442,114.595590875792,2.4389445623122,Rhabdomyosarcoma_histology_II; rhabdomyosarcoma_disease_subtype_I; Sarcoma_histology_I; soft_tissue_disease,ATL_histology_II; ATL_disease_subtype_I; Lymphoma_histology_I; lymphocyte_disease; haematopoietic_and_lymphoid_tissue_primary_tissue,0.023239442519533655,Core_omics: [MYH13_(8735)_RNAseq],NA,NA,0.1588825006215822,Core_omics: [NME9_(347736)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-3,59,84.62,73.17,88.8,83.68,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84465,MEGF11,multiple EGF like domains 11,0,0,0.0029154518950437317,0,-0.5190340447414195,-5.713217298535997,-0.911076913730541,-4.142258934546562,-0.0063059830805482575,0.008054019730170423,-0.24075725620181718,-0.04003666890103672,0.04421829123944801,-0.7202449937560096,FALSE,FALSE,0.9893262918433401,0.3978285282781193,77.8387309799377,18.0688882671801,plasmacytoma_disease_subtype_II; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,med_group_3_disease_subtype_II; breast_adenocarcinoma_disease_subtype_I; malignant_rhabdoid_tumor_disease_subtype_I; breast_disease; ERpos_HER2pos_disease_subtype_II,0.0372914270518618,DNA_based: [DPP8_(54878)_CN],NA,NA,0.34007901762715276,Core_omics: [PMAIP1_(5366)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-1.55,63,7.41,6.32,3.58,7.48,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
150365,MEI1,meiotic double-stranded break formation protein 1,0,0,NA,NA,-0.4850436431400743,-6.366682382037158,NA,NA,0.04429750923678559,0.006912656042367896,-0.45907406889842395,NA,NA,NA,FALSE,NA,0.9987870770808716,NA,79.3036570722734,NA,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,NA,0.11372459701439862,Core_omics: [CEACAM16_(388551)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,1.55,95,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
101928601,MEI4,meiotic double-stranded break formation protein 4,9.066183136899365e-4,0,NA,NA,-0.6890887419282363,-7.059851729964421,NA,NA,0.05223524627218302,0.011026176667489182,-0.24065704925438733,NA,NA,NA,FALSE,NA,0.9908481823452042,NA,101.253957468288,NA,uterine_carcinosarcoma_disease_subtype_I; uvea_primary_tissue; uveal_melanoma_disease_subtype_I; eye_disease; SCCOHT_disease_subtype_I,NA,0.06312539043811924,Related: [cas9_activity_crispr_confounders; cell_line_NNMD_crispr_confounders; MEI4_(101928601)_CN; REC114_(283677)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
644890,MEIG1,meiosis/spermiogenesis associated 1,0,0,NA,NA,-0.4015216982426328,-3.7389536886315278,NA,NA,0.05707163331959643,0.015043721982729732,-0.13809809389315125,NA,NA,NA,FALSE,NA,0.9951270336767283,NA,112.752944928095,NA,DLBCL_disease_subtype_II; mixed_germ_cell_disease_subtype_I; M2_disease_subtype_II; Synovial_histology_II; synovial_sarcoma_disease_subtype_I,NA,0.20441747592966547,Related: [cell_line_NNMD_crispr_confounders; cas9_activity_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,2.8,25.04,65.46,0.13,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
254528,MEIOB,meiosis specific with OB-fold,0,0,0.0029154518950437317,0,-0.3832354478958676,-3.830328923568139,-0.716115852630618,-3.7025399835397064,-0.023215791958553462,0.008834465623701533,-0.1454576538202033,0.010939737755626167,0.03855988428444021,-0.3086595113164133,FALSE,FALSE,0.9961055749976915,0.6528067032868987,50.0873314457999,6.90000185453093,tubular_disease_subtype_II; b_cell_disease_subtype_II; Osteosarcoma_histology_II; osteosarcoma_disease_subtype_I; ERneg_HER2pos_disease_subtype_II,prostate_adenocarcinoma_disease_subtype_I; prostate_disease; breast_primary_tissue; engineered_breast_disease; breast_adenocarcinoma_disease_subtype_I,0.18284683939719998,Related: [cell_line_NNMD_crispr_confounders; cas9_activity_crispr_confounders; HECW2_(57520)_CN; MEIOB_(254528)_CN],NA,NA,0.1826281627907235,Core_omics: [SIRPB1_(10326)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.3,76,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
284071,MEIOC,meiosis specific with coiled-coil domain,0.27379873073436084,2,0.0029154518950437317,0,-1.2402689634906834,-6.69083167477524,-0.845282113399637,-4.061790133714905,-0.33018471000642746,0.018501331804285037,-0.5744560181086198,-0.05334719360722973,0.038014039871544045,-0.4601916994752768,TRUE,FALSE,0.9984419353316096,0.950858336241107,54.931400698068,7.86816932639101,Synovial_histology_II; synovial_sarcoma_disease_subtype_I,breast_disease; breast_primary_tissue; breast_carcinoma_disease_subtype_I; Carcinoma_histology_II; ATRT_disease_subtype_I,0.24291314133610417,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.1753930594191524,Core_omics: [FAM117A_(81558)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,-0.7,72,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
4211,MEIS1,Meis homeobox 1,0.005439709882139619,0,0,0,-0.7527218852974286,-6.971325184337567,-0.90180898276,-4.948295847651094,-0.0015197847549622994,0.01161135504072538,-0.9521232252627237,0.005604560262568392,0.03362785755029126,-0.42764334127735754,FALSE,FALSE,0.8813940924265277,0.9928594393515934,154.913128720522,41.1543189097993,autonomic_ganglia_primary_tissue; Leukemia_histology_I; blood_disease; peripheral_nervous_system_disease; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I,M3_disease_subtype_II; Chondrosarcoma_histology_II; chondrosarcoma_disease_subtype_I; AML_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue,0.17849130363977825,Related: [MEIS1_(4211)_RNAseq],NA,NA,0.20862922544218712,Core_omics: [CASZ1_(54897)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,50.45,44.86,62.45,84.14,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4212,MEIS2,Meis homeobox 2,0.011786038077969175,2,0,0,-1.103142480377619,-9.164374788709821,-0.82663357071282,-6.632990136160853,0.020340229036135193,0.015028896793698608,-1.9618361939740283,0.038506719332127765,0.0170119607758494,-0.42350196913040494,FALSE,FALSE,0.9531268166511208,0.9990027197931957,360.918348794673,78.641683826262,follicular_disease_subtype_II; Rhabdoid_histology_I; malignant_rhabdoid_tumor_disease_subtype_I; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I,MMMT_disease_subtype_I; glioma_disease_subtype_I; central_nervous_system_disease; central_nervous_system_primary_tissue; endometrioid_disease_subtype_II,0.3469544546488833,Related: [MEIS2_(4212)_RNAseq],NA,NA,0.1430713560256114,Core_omics: [SHOX2_(6474)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.55,73,64.39,71.34,31.73,83.21,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
56917,MEIS3,Meis homeobox 3,0.07524932003626474,1,0.010968921389396709,1,-0.9132548862758244,-4.97600902689854,-1.45693910552153,-6.631173508876094,-0.23397862478040754,0.018635049739434185,-0.2101830179092104,0.0540149910693251,0.05191845470382327,-1.102111779825152,FALSE,FALSE,0.993526223459829,0.997964197973273,77.0193854465178,64.3248187665976,M3_disease_subtype_II; brenner_tumor_disease_subtype_I,b_cell_disease_subtype_II; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; ALL_disease_subtype_I,0.15882257241791142,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.3356684155699192,Core_omics: [SERINC2_(347735)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,24.56,9.92,25.84,23.24,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
9833,MELK,maternal embryonic leucine zipper kinase,0.011786038077969175,0,0,0,-0.8856839025422301,-7.316718836228225,-0.67685718228107306,-4.645660376942284,-0.08866967980112918,0.011865865191241004,-0.8460029988970346,0.0019419286590594625,0.021349495407285497,-0.13583234789983803,FALSE,FALSE,0.985007473142886,1,145.223009119942,33.6634045647127,renal_cell_carcinoma_disease_subtype_I; kidney_disease; kidney_primary_tissue; clear_cell_disease_subtype_II,mixed_serous_clear_cell_disease_subtype_II; autonomic_ganglia_primary_tissue; renal_cell_carcinoma_disease_subtype_I; kidney_disease; kidney_primary_tissue,0.15570579915795918,Core_omics: [GLS_(2744)_RNAseq],NA,NA,0.16636170494814054,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,1.7,96,91.68,78.15,87.41,75.16,FALSE,FALSE,TRUE,OTS167,TRUE,3,Phase I/II,FALSE,FALSE,TRUE
4241,MELTF,melanotransferrin,9.066183136899365e-4,0,NA,NA,-0.4785477658527826,-5.019352144112496,NA,NA,-0.041716183757290214,0.007574129524090225,-0.2605638712096197,NA,NA,NA,FALSE,NA,0.995638363494907,NA,79.6479950407929,NA,CLL_disease_subtype_I; alveolar_disease_subtype_II; SCCOHT_disease_subtype_I; t_cell_disease_subtype_II; oral_disease_subtype_II,NA,0.1118963957045249,Core_omics: [FAM136A_(84908)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,-3,59,81.91,46.11,76.85,31.45,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
51072,MEMO1,mediator of cell motility 1,0.2484134179510426,12,0.0029154518950437317,0,-0.9679765193346108,-3.72743845432704,-0.663198603051013,-3.949846482086768,-0.30911449616738895,0.03124409778782387,-0.43321135475990996,-0.007893490519008192,0.027524958942382646,-0.4842810344669148,FALSE,FALSE,0.9890564692825915,0.7892156938297421,38.6827429754366,17.8391488939178,soft_tissue_disease; soft_tissue_primary_tissue; malignant_rhabdoid_tumor_disease_subtype_I; Rhabdoid_histology_I,gastric_disease; Adenocarcinoma_histology_II; gastric_adenocarcinoma_disease_subtype_I,0.3031937058541858,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.17758080305978505,Core_omics: [EMP3_(2014)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,14.13,41.13,41.15,52.48,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4221,MEN1,menin 1,0.2883046237533998,70,0.01267605633802817,0,-1.5730728492693955,-4.511216611136692,-0.893728205286683,-4.068317714679026,-0.2984016487751366,0.07983787806848062,-0.5760402174545434,-0.19535038557216935,0.02946803331748935,-0.312797500934824,FALSE,FALSE,0.9645524065652337,0.974787301107824,96.8142126771574,13.5655056335703,Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue; Leukemia_histology_I; blood_disease,CML_disease_subtype_I; blast_crisis_disease_subtype_II; breast_disease,0.29961551475751597,Related: [SMAD3_(4088)_RNAseq],NA,NA,0.2523461132437972,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,-0.9,70,84.81,95.51,26.16,99.18,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4222,MEOX1,mesenchyme homeobox 1,0,0,0,0,-0.539466566775587,-6.404549525636249,-0.788787682390612,-4.724082955181872,-0.010162678892057655,0.006830193246418581,-0.4447710761380111,0.03527368461583752,0.03042874762821868,-0.17885613041930176,FALSE,FALSE,0.9652073459507924,0.9942714247977888,72.2469878162897,27.0110689044056,clear_cell_carcinoma_disease_subtype_I; spleen_primary_tissue; uvea_primary_tissue,ERneg_HER2pos_disease_subtype_II; breast_primary_tissue; breast_disease; breast_carcinoma_disease_subtype_I; Carcinoma_histology_II,0.06943157399377693,Related: [UBE2R2_(54926)_CN],NA,NA,0.11059027716343625,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,8.92,53.22,13.32,67.73,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4223,MEOX2,mesenchyme homeobox 2,9.066183136899365e-4,0,0,0,-0.6026673932326344,-6.054716907297755,-0.628688156153712,-4.293450082174932,0.009747727423054688,0.010230671160196771,1.8372081215564038,-0.059991492650174054,0.017544804153703106,-0.300560780512327,FALSE,FALSE,0.9935856857423921,0.9581857318120475,291.146479806264,39.0049941327726,Synovial_histology_II; synovial_sarcoma_disease_subtype_I; soft_tissue_primary_tissue; Sarcoma_histology_I; soft_tissue_disease,melanoma_disease_subtype_I; skin_disease; Melanoma_histology_II; cervical_squamous_disease_subtype_I; skin_primary_tissue,0.10555629803278994,Related: [MEOX2_(4223)_RNAseq],NA,NA,0.25463127391670576,Core_omics: [LYST_(1130)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,5.23,85.77,82.23,87.04,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4224,MEP1A,meprin A subunit alpha,9.066183136899365e-4,0,0.005633802816901409,0,-0.5238387271004653,-5.27895714540215,-1.24143910244052,-5.8068045177117735,-0.0016206310386247687,0.009786052949802872,0.024516272682539093,-0.07487041986269366,0.040359540631405996,-0.7495712239347417,FALSE,FALSE,0.9930701508238636,0.9901801078662191,122.117806724733,52.4608890645194,WDLPS_histology_II; WDLPS_disease_subtype_II; Rhabdomyosarcoma_histology_II; Liposarcoma_histology_I; liposarcoma_disease_subtype_I,ERpos_HER2pos_disease_subtype_II; Synovial_histology_II; synovial_sarcoma_disease_subtype_I,0.1947533547653386,Core_omics: [FGFBP3_(143282)_RNAseq],NA,NA,0.18032589047554232,Core_omics: [NBPF10_(100132406)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-1.9,59,95.2,65.36,95.26,55.12,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4225,MEP1B,meprin A subunit beta,0,0,0.0018281535648994515,0,-0.3291173155805796,-4.108166907920998,-0.616656698627241,-3.6566172096464915,0.014436698809347085,0.006993488986798285,0.08508186930242868,0.06598773035944132,0.03485219239723809,-0.0654466156506412,FALSE,FALSE,0.9991075309005024,0.9936877777178557,33.5386838565814,0.749443074061332,uterine_carcinosarcoma_disease_subtype_I; Undifferentiated_histology_II; undifferentiated_sarcoma_disease_subtype_I; eye_primary_tissue; upper_aerodigestive_disease,tongue_disease_subtype_II; NSCLC_disease_subtype_I; NSCLC_mucoepidermoid_disease_subtype_II; NSCLC_squamous_disease_subtype_II,0.15074881972771986,Core_omics: [RNPC3_(55599)_RNAseq],NA,NA,0.15966407434525914,Core_omics: [VDR_(7421)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-3,59,97.32,71.46,98.16,63.89,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
56257,MEPCE,methylphosphate capping enzyme,1,1090,0.025906735751295335,2,-2.447880774688246,-3.5704520068767542,-0.974507002741193,-4.36351878590743,-1.5187961362718283,0.06771176889147829,0.27194119650155335,-0.16590972316897254,0.03433925364587675,-0.4067058887330276,TRUE,FALSE,0.9904783466441293,0.9600052977679238,16.9972764434051,36.0502973394531,NA,thyroid_squamous_disease_subtype_I; uvea_primary_tissue; mucinous_disease_subtype_II; eye_disease; uveal_melanoma_disease_subtype_I,0.25792967311556336,Core_omics: [ADRA2C_(152)_RNAseq],NA,NA,0.2368197307878948,DNA_based: [CUX1_(1523)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,ARAF (new),NA,TRUE,ARAF (new),NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
56955,MEPE,matrix extracellular phosphoglycoprotein,0.003626473254759746,0,0,0,-0.6012463398866809,-4.7110702494713275,-0.353787300130933,-3.1224050317270367,-0.12101349245773427,0.010391172715664783,0.025459038335239947,0.12976899356343274,0.02398366802213662,-0.0252158274947059,FALSE,FALSE,0.9932284499037862,0.9108759975569163,55.1518958213244,11.1854229303583,spleen_primary_tissue; ERneg_HER2pos_disease_subtype_II,Fibrosarcoma_histology_II; fibrosarcoma_disease_subtype_I; breast_disease; ERneg_HER2pos_disease_subtype_II; breast_ductal_carcinoma_disease_subtype_I,0.14756155342983016,Core_omics: [IRF2_(3660)_RNAseq],NA,NA,0.26152270109153847,Core_omics: [PRAC1_(84366)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,-3,59,26.77,24.23,50.45,34.65,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
10461,MERTK,"MER proto-oncogene, tyrosine kinase",0.003626473254759746,0,0.0014064697609001407,0,-0.6561165832022939,-6.054904324975005,-0.776131769328526,-4.250352343787837,-0.028370848966222786,0.010748626453373959,-0.5238097594640222,-0.16294899051144382,0.020812777024560757,-0.1527381527705648,FALSE,FALSE,0.9827716660087586,0.9955830875167381,79.4724080955589,26.9057307995294,M6_disease_subtype_II; Ewing_sarcoma_disease_subtype_I; plasmacytoma_disease_subtype_II; bone_disease,engineered_breast_disease; prostate_small_cell_disease_subtype_I,0.10500725208150208,Related: [MET_(4233)_RNAseq],NA,NA,0.15355706910422673,Core_omics: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,0.7,87,96.01,95.13,89.14,84.47,FALSE,FALSE,FALSE,BMS-777607|LDC1267|MK-2461|UNC2025|UNC2250,TRUE,2,Phase I,FALSE,FALSE,TRUE
23184,MESD,mesoderm development LRP chaperone,0.028105167724388033,0,0.011661807580174927,1,-0.6895972036229412,-4.444159250922763,-1.47164492503841,-7.5320229462417245,-0.13703851140158668,0.015458864992200337,-0.3424898405086171,-0.24934675502284775,0.026334862445695023,-1.7050883607351048,FALSE,FALSE,0.9901241373781695,0.8037182244949443,93.5239154539604,51.2426835626877,melanoma_disease_subtype_I; skin_disease; Melanoma_histology_II; skin_primary_tissue; pancreas_disease,ERneg_HER2pos_disease_subtype_II,0.29907387769514326,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.2699009814168659,Related: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,32.6,55.33,17.17,65.34,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
55897,MESP1,mesoderm posterior bHLH transcription factor 1,0,0,0,0,-0.4691253581605909,-6.32809992527093,-0.841189949088079,-5.3981872539763005,0.054227351788535307,0.006839782597452118,-0.46277385530077175,0.0654452106865706,0.028207800510703533,-0.03527923603191475,FALSE,FALSE,0.9910003442958749,0.9922956722439633,95.6663675496884,100.203959813168,renal_leiomyoblastoma_disease_subtype_II; diffuse_gastric_disease_subtype_II; brenner_tumor_disease_subtype_I; endometrial_adenocarcinoma_disease_subtype_I; malignant_rhabdoid_tumor_disease_subtype_I,breast_ductal_carcinoma_disease_subtype_I; breast_disease; ERpos_HER2pos_disease_subtype_II; merkel_cell_carcinoma_disease_subtype_I; ERneg_HER2neg_disease_subtype_II,0.059140515758509864,Related: [cell_line_NNMD_crispr_confounders; cas9_activity_crispr_confounders],NA,NA,0.2069831138400826,Core_omics: [COL5A1_(1289)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
145873,MESP2,mesoderm posterior bHLH transcription factor 2,9.066183136899365e-4,0,0,0,-0.5531456293714414,-5.350432639410971,-0.718758370731761,-5.489385097416649,-0.03574416101809721,0.009351418909091927,-0.4449529421247959,0.09142572962621576,0.021783117501074083,-0.4204448246865806,FALSE,FALSE,0.9948980904830105,0.9669769389664703,66.8333049753926,41.7016419390396,ATL_histology_II; ATL_disease_subtype_I; M2_disease_subtype_II; haematopoietic_and_lymphoid_tissue_primary_tissue; Teratoma_histology_I; Testicular_histology_II; teratoma_disease_subtype_I; testicular_disease_subtype_II,autonomic_ganglia_primary_tissue; ERneg_HER2neg_disease_subtype_II; breast_disease; ERpos_HER2pos_disease_subtype_II; Neuroblastoma_histology_I; peripheral_nervous_system_disease; neuroblastoma_disease_subtype_I,0.11132092318905941,Core_omics: [FLOT1_(10211)_RNAseq],NA,NA,0.20565926838714246,Core_omics: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4232,MEST,mesoderm specific transcript,0.001813236627379873,0,0,0,-0.8337863103628814,-8.349167519419462,-0.574700683897758,-4.726757104225323,-0.032925422685676775,0.009200847203259883,-0.567066998604193,0.0695985393166443,0.018580125549382417,-0.4571127151221547,FALSE,FALSE,0.9944641398678271,0.9473109349052047,153.290129966477,23.1334741990456,mixed_endometrioid_clear_cell_disease_subtype_II; unspecified_leukemia_disease_subtype_I; Placenta_primary_tissue; b_cell_burkitt_disease_subtype_II; haematopoietic_and_lymphoid_tissue_primary_tissue,malignant_rhabdoid_tumor_disease_subtype_I; Rhabdoid_histology_I; mixed_serous_clear_cell_disease_subtype_II; soft_tissue_disease; Leiomyosarcoma_histology_II; leiomyosarcoma_disease_subtype_I,0.0782813530224886,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.2420415322898656,Core_omics: [RPLP0_(6175)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,TRUE,-3,59,28.78,49.88,42.72,60.96,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4233,MET,"MET proto-oncogene, receptor tyrosine kinase",0.02901178603807797,10,0.004219409282700422,3,-1.6047205479089168,-10.806720298560549,-1.22650099564613,-8.62924838218832,-0.08912660153549112,0.019668801691082653,-4.086730734924942,0.032532405346434506,0.021287691302647183,-2.3833508268085244,FALSE,FALSE,0.9773773958712838,0.9996972096373166,1005.13904366621,272.373575521477,glioma_disease_subtype_I; central_nervous_system_disease; central_nervous_system_primary_tissue; Rhabdoid_histology_I; Glioblastoma_histology_II; glioblastoma_disease_subtype_II,diffuse_gastric_disease_subtype_II; gastric_adenocarcinoma_disease_subtype_I; gastric_disease; liver_primary_tissue; Oligodendroglioma_histology_II; oligodendroglioma_disease_subtype_II,0.47524499640316537,Related: [HGF_(3082)_RNAseq; MET_(4233)_RNAseq],NA,Core_omics: [HGF_(3082)_RNAseq],0.4175940683575675,Related: [MET_(4233)_RNAseq; HGF_(3082)_RNAseq],NA,NA,TRUE,Copy Number,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,1.5,94,99.95,99.95,96.93,99.79,FALSE,FALSE,TRUE,alectinib|altiratinib|AMG-208|AMG-337|AMG458|amuvatinib|BMS-536924|BMS-777607|BMS-817378|cabozantinib|crizotinib|EMD-1214063|foretinib|golvatinib|INC-280|JNJ-38877605|LY2801653|MGCD-265|MK-2461|MK-8033|NVP-BVU972|PF-04217903|PHA-665752|savolitinib|SGX523|SU-11274|tivantinib,TRUE,0,NA,TRUE,TRUE,TRUE
23173,METAP1,methionyl aminopeptidase 1,0.5847688123300091,183,0.0018281535648994515,0,-1.4572202692293643,-3.591264223991672,-0.985879177072215,-5.861380071472779,-0.49352494202893604,0.07200866975333839,-0.29837532356926855,0.0534946747885264,0.03144443581101813,-0.008475918850834598,FALSE,FALSE,0.902581306978799,0.9950884314347082,17.5035174412342,20.5964976310144,exocrine_adenocarcinoma_disease_subtype_II; pancreas_disease; upper_aerodigestive_disease; exocrine_disease_subtype_I; upper_aerodigestive_tract_primary_tissue,breast_primary_tissue; Carcinoma_histology_II; breast_carcinoma_disease_subtype_I; ERneg_HER2neg_disease_subtype_II; breast_disease,0.47004904836418715,Core_omics: [SH3BP4_(23677)_RNAseq],NA,DNA_based: [Haematopoietic_and_Lymphoid_Lin; cell_line_NNMD_crispr_confounders; Solid_Lin] | Related: [Solid_Lin],0.2830108277091829,Related: [HNRNPU_(3192)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.3,76,29.23,17.41,15.43,46.83,FALSE,FALSE,FALSE,NA,FALSE,0,Discontinued,FALSE,FALSE,TRUE
254042,METAP1D,"methionyl aminopeptidase type 1D, mitochondrial",0,0,0,0,-0.32448915782309345,-3.799667159575198,-0.690973840934979,-5.003011856016999,-0.01695868344801724,0.006550662217115071,0.11849174299766403,0.059962814404833115,0.022529084495137745,-0.330639742581096,FALSE,FALSE,0.8629252858750256,0.995708036368821,32.1538803640924,11.7949047509769,esophagus_squamous_disease_subtype_I; CML_disease_subtype_I; esophagus_disease,breast_carcinoma_disease_subtype_I; Carcinoma_histology_II; ERneg_HER2pos_disease_subtype_II; breast_disease; pericardial_effusion_primary_tissue,0.20341771983178963,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.2894600897160436,Core_omics: [SMARCA1_(6594)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,TRUE
10988,METAP2,methionyl aminopeptidase 2,0.7126019945602902,269,0.4519774011299435,80,-1.5334377609220309,-3.561836483916289,-1.89423707494606,-4.69477195044945,-0.5707190466316389,0.07305515594363611,-0.06258757247915162,-0.5390287977249967,0.08332649009989604,-0.5513474180524537,TRUE,FALSE,0.9834359737033446,0.8510569167774706,7.47373812864339,34.7507440294975,NA,melanoma_disease_subtype_I; Melanoma_histology_II; skin_disease; skin_primary_tissue; pancreas_disease,0.40653232844628867,Related: [Haematopoietic_and_Lymphoid_Lin],NA,NA,0.37653777553434703,Core_omics: [EIF4A1_(1973)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,TRUE,BRAF (new),NA,TRUE,BRAF (new),NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,1.7,96,78.17,80.4,72.36,78.19,FALSE,FALSE,FALSE,AGM-1470|fumagillin|methionine|nitroxoline|oxyquinoline,TRUE,0,Launched,FALSE,FALSE,TRUE
79006,METRN,"meteorin, glial cell differentiation regulator",9.066183136899365e-4,0,0,0,-0.4652133804289666,-4.5345474974169795,-0.528680849366989,-3.545706783383765,-0.011909050582915933,0.009993366705405205,-0.431635585871379,0.03844534158516967,0.02558313556168118,0.19014448617706664,FALSE,FALSE,0.9966575206351506,0.9935109519820026,73.7218311748936,7.14292194905545,Rhabdoid_histology_I; soft_tissue_disease; ATRT_disease_subtype_I; malignant_rhabdoid_tumor_disease_subtype_I; soft_tissue_primary_tissue,ovary_carcinoma_disease_subtype_I,0.09685125105763698,Related: [cas9_activity_crispr_confounders; cell_line_NNMD_crispr_confounders; METRNL_(284207)_RNAseq; METRNL_(284207)_CN; METRN_(79006)_RNAseq],NA,NA,0.18690945095084896,Core_omics: [RAB28_(9364)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
284207,METRNL,"meteorin like, glial cell differentiation regulator",0.001813236627379873,0,0,0,-0.5532851756070555,-5.9507637278253656,-0.51973237439992,-3.644887539607713,-0.007965136445171089,0.00839764478172417,-0.3857581347872211,-0.07731771301233255,0.014732985302972613,-0.2992896450302071,FALSE,FALSE,0.8643327379753489,0.9923780729975225,102.801403535876,20.7302425824023,brenner_tumor_disease_subtype_I; M3_disease_subtype_II; bladder_transitional_cell_disease_subtype_II; urinary_tract_primary_tissue,eye_disease; uveal_melanoma_disease_subtype_I; clear_cell_disease_subtype_II; uvea_primary_tissue,0.1439289483322077,Core_omics: [SHC4_(399694)_RNAseq],NA,NA,0.12088179558701877,Core_omics: [KATNAL2_(83473)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4234,METTL1,methyltransferase like 1,0.5312783318223028,162,0.0033333333333333335,0,-1.4352427514179666,-3.7576783049937172,-0.940334926965037,-5.35464016853818,-0.47006452304719487,0.06597445921841169,-0.8051649446515166,-0.11563484514041626,0.023720917994886164,-1.1465567669576615,TRUE,FALSE,0.997205489527413,0.9956561572397031,151.234459522446,59.0149039059952,rhabdomyosarcoma_disease_subtype_I; Leukemia_histology_I; blood_disease; upper_aerodigestive_disease; upper_aerodigestive_squamous_disease_subtype_I,breast_adenocarcinoma_disease_subtype_I; merkel_cell_carcinoma_disease_subtype_I; skin_disease; spleen_primary_tissue; skin_primary_tissue,0.2816410557651513,Core_omics: [GOLT1A_(127845)_RNAseq],NA,NA,0.18695609398341564,Core_omics: [SSMD_rnai_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,73.44,67.15,77.63,52.76,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
339175,METTL2A,methyltransferase like 2A,NA,NA,0,0,NA,NA,-0.627899385977291,-3.6510925667501257,NA,NA,NA,-0.01729262537590256,0.027969038018864568,-0.020013280053076378,NA,FALSE,NA,0.9883977723270606,NA,2.90928744765324,NA,urinary_tract_primary_tissue; urinary_tract_disease; bladder_carcinoma_disease_subtype_I; engineered_kidney_disease; bladder_transitional_cell_disease_subtype_II,NA,NA,NA,NA,0.25633087571620544,Core_omics: [UBE2T_(29089)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-3,59,18.63,9.74,32.06,19.48,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
55798,METTL2B,methyltransferase like 2B,NA,NA,0.009859154929577466,0,NA,NA,-0.812958204795084,-3.4349804871943372,NA,NA,NA,-0.1362569167168088,0.03881016218350926,0.09869498157952031,NA,FALSE,NA,0.9928209661868953,NA,3.27249770361357,NA,tongue_disease_subtype_II; NSCLC_disease_subtype_I,NA,NA,NA,NA,0.12238577490064098,Core_omics: [ERFE_(151176)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-3,59,41.04,34.04,60.81,37.41,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
56339,METTL3,methyltransferase like 3,0.7633726201269265,186,0.0014084507042253522,0,-1.1725837134540058,-3.008046331402969,-0.679896043954857,-3.911402219128459,-0.5595557478603395,0.041532830678085234,-0.1138911158495912,0.023919897690788807,0.032378240409031984,-0.3578768974808558,TRUE,FALSE,0.9597019377828816,0.9308250068725575,4.63519896970604,39.2503904333936,haematopoietic_and_lymphoid_tissue_primary_tissue,NSCLC_adenosquamous_disease_subtype_II; tubular_disease_subtype_II; uvea_primary_tissue; renal_cell_carcinoma_disease_subtype_I; eye_disease; uveal_melanoma_disease_subtype_I,0.20930365651702423,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.21868791645308702,Core_omics: [SLPI_(6590)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
64863,METTL4,methyltransferase like 4,0.001813236627379873,0,0.003656307129798903,0,-0.4763117124791787,-4.8154470778617,-0.871106401014745,-5.0287156846655465,0.04984666347505069,0.011938774467584531,-0.47923773503772543,0.048682101743028575,0.03345505816295863,-1.073582169244468,FALSE,FALSE,0.99785310876274,0.9940208879583522,68.1910674064691,88.8973510940137,mucosal_disease_subtype_II; large_intestine_primary_tissue; colorectal_disease; colorectal_adenocarcinoma_disease_subtype_I; ovary_carcinoma_disease_subtype_I,breast_primary_tissue; breast_disease; breast_ductal_carcinoma_disease_subtype_I; ERneg_HER2neg_disease_subtype_II,0.12125535683459865,DNA_based: [DYNC2I1_(55112)_CN],NA,NA,0.12829600774236757,Core_omics: [ING5_(84289)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
29081,METTL5,methyltransferase like 5,0.1214868540344515,6,NA,NA,-1.0401439487458592,-4.675356514118855,NA,NA,-0.2163970909048606,0.031042599067285986,-0.3057607007844271,NA,NA,NA,FALSE,NA,0.9168035698774735,NA,29.5026235625008,NA,CML_disease_subtype_I; Leukemia_histology_I; blood_disease; AML_disease_subtype_I; prostate_hyperplasia_disease_subtype_I,NA,0.178134160453778,Core_omics: [APOL4_(80832)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-0.1,78,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
131965,METTL6,methyltransferase like 6,0,0,NA,NA,-0.4309205251307703,-4.085902134559687,NA,NA,0.022490321737095434,0.012314247852387378,-0.062466457190708063,NA,NA,NA,FALSE,NA,0.9909514253060321,NA,67.9122129202551,NA,Meningioma_histology_II; meningioma_disease_subtype_I; serous_disease_subtype_II; exocrine_adenocarcinoma_disease_subtype_II; pancreas_disease,NA,0.14980991064000776,Core_omics: [MAPRE3_(22924)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-0.35,75,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
25840,METTL7A,methyltransferase like 7A,0.08522212148685404,0,NA,NA,-0.7732981167742431,-4.140965214677161,NA,NA,-0.24070523753952366,0.016541982102916623,-0.17090153599866154,NA,NA,NA,FALSE,NA,0.8686529579841323,NA,50.1131424694815,NA,bone_primary_tissue; Osteosarcoma_histology_II; osteosarcoma_disease_subtype_I; mucinous_disease_subtype_II; bone_disease,NA,0.31702796003424977,Related: [cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
196410,METTL7B,methyltransferase like 7B,0.006346328195829556,0,NA,NA,-0.5359783260209358,-3.8850341900535086,NA,NA,-0.11383159025848706,0.011806935224874325,-0.36288648740608653,NA,NA,NA,FALSE,NA,0.25951790132789454,NA,37.274808269538,NA,Myeloma_histology_II; Choriocarcinoma_histology_II; choriocarcinoma_disease_subtype_I; brenner_tumor_disease_subtype_I; upper_aerodigestive_disease,NA,0.23356692632697817,DNA_based: [cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,-1.1,67,23.9,7.37,25.64,5.25,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
51108,METTL9,methyltransferase like 9,0,0,0.0058309037900874635,0,-0.6352808830304757,-5.7988779886305934,-0.816386883560043,-4.677404511783809,0.021568912863452076,0.012830518182694383,-0.4200544570092673,0.017900391739624235,0.031814227249919044,-0.708742904238604,FALSE,FALSE,0.9907506167983705,0.9958279818448583,58.7984302598582,16.8816040509846,tubular_disease_subtype_II; uvea_primary_tissue; stomach_primary_tissue; clear_cell_carcinoma_disease_subtype_I; diffuse_gastric_disease_subtype_II,breast_primary_tissue; breast_disease; breast_ductal_carcinoma_disease_subtype_I; ERneg_HER2neg_disease_subtype_II; ERneg_HER2pos_disease_subtype_II,-0.03182510053699483,Core_omics: [MOSPD1_(56180)_RNAseq],NA,NA,0.20412957756223185,Core_omics: [TRIP6_(7205)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,-3,59,4.19,24.87,65.93,2.26,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
149281,METTL11B,methyltransferase like 11B,0.004533091568449683,0,NA,NA,-0.6397416815521931,-4.616107992680531,NA,NA,-0.0764602207171146,0.01489014731004516,0.7245232263023049,NA,NA,NA,FALSE,NA,0.9085497809344776,NA,183.496176857133,NA,Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I; embryo_carcinoma_disease_subtype_I; autonomic_ganglia_primary_tissue; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,NA,0.19789093884191125,Related: [METTL11B_(149281)_CN; cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
57721,METTL14,methyltransferase like 14,0.8703535811423391,574,0.0014084507042253522,0,-1.840339870345701,-3.5193009768705754,-1.16946080987838,-7.8100815302271025,-0.7834203560608458,0.09019262207650397,0.06568596732406137,0.023064900844042197,0.02331440665275497,-0.5478463197435305,TRUE,FALSE,0.9509622681929971,0.7755675345445754,0.667168750617577,38.6800539081312,upper_aerodigestive_tract_primary_tissue; pancreas_disease; upper_aerodigestive_disease,ERpos_HER2neg_disease_subtype_II; M7_disease_subtype_II; breast_ductal_carcinoma_disease_subtype_I,0.5369591907390032,Related: [cell_line_NNMD_crispr_confounders],NA,Core_omics: [cell_line_NNMD_crispr_confounders] | DNA_based: [cell_line_NNMD_crispr_confounders],0.13374826296748732,Core_omics: [PACSIN3_(29763)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,11.58,10.59,3.9,19.12,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
196074,METTL15,methyltransferase like 15,0.4496826835902085,20,NA,NA,-1.0636625772629102,-4.049542138042551,NA,NA,-0.40038701967717427,0.026827249102188283,-0.42353553838312674,NA,NA,NA,TRUE,NA,0.9935072827834689,NA,49.2797190729807,NA,engineered_disease; eye_primary_tissue,NA,0.3282245150545395,Core_omics: [PLAU_(5328)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,-1.25,66,7.74,4.29,7.77,3.75,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
79066,METTL16,methyltransferase like 16,0.9492293744333635,767,0,0,-1.8724375241339424,-2.8008851243423623,-0.431727494132213,-2.886472246785421,-0.9646758153323371,0.10503961584140735,-0.16377327832721172,-0.01573371145755132,0.02077011529795334,-0.11424935762691157,TRUE,FALSE,0.9912582571161629,0.9974108027323842,5.08701996866193,1.06116837319223,NA,ERpos_HER2neg_disease_subtype_II; breast_disease; breast_carcinoma_disease_subtype_I,0.4393556090101507,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.26344314429469246,Core_omics: [TCF12_(6938)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,1.18,1.15,1.1,1.07,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
64745,METTL17,methyltransferase like 17,0.5820489573889392,143,NA,NA,-1.2205415838271587,-3.4715972541834343,NA,NA,-0.4736133261807846,0.04629127123558237,-0.46299785737333987,NA,NA,NA,TRUE,NA,0.5190237737487082,NA,46.2768383031652,NA,Rhabdoid_histology_I; malignant_rhabdoid_tumor_disease_subtype_I; non_hodgkin_lymphoma_disease_subtype_I,NA,0.3659032703735884,Core_omics: [TGFBI_(7045)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,0.2,82,11.5,46.61,30.49,67.25,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
92342,METTL18,methyltransferase like 18,0,0,0,0,-0.40745404645514016,-3.9294583462500974,-0.654040556238589,-4.4920614227966755,0.06329081597831589,0.014351781011688231,-0.054974334589643375,0.08100372706585547,0.02677537959356044,-0.7234475617193836,FALSE,FALSE,0.9889466741453445,0.8234596018397004,32.7555016458009,17.5612409301597,Osteosarcoma_histology_II; osteosarcoma_disease_subtype_I; undifferentiated_disease_subtype_II; plasmacytoma_disease_subtype_II; bone_disease,ERneg_HER2pos_disease_subtype_II; merkel_cell_carcinoma_disease_subtype_I; breast_disease,0.14195282788041116,Core_omics: [ARG2_(384)_RNAseq],NA,NA,0.254656229342454,Core_omics: [NUDT8_(254552)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,0,80,72.56,37.54,75.58,29.99,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
151194,METTL21A,methyltransferase like 21A,9.066183136899365e-4,0,NA,NA,-0.4437127882131667,-4.633954246374415,NA,NA,-0.012155631477486986,0.008673076226978573,0.4547599977148251,NA,NA,NA,FALSE,NA,0.7952295169597808,NA,140.99429469502,NA,ATL_histology_II; ATL_disease_subtype_I; thyroid_sarcoma_disease_subtype_I; SCCOHT_disease_subtype_I; B-cell_histology_II,NA,0.0742492083026949,DNA_based: [GDPD4_(220032)_MutDrv],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,71.97,56.53,50.71,63.78,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
196541,METTL21C,methyltransferase like 21C,0,0,0.0029154518950437317,0,-0.5560411885233806,-5.8383197778507325,-0.742559492734099,-3.4513288789793406,0.021040808525386947,0.009770106434790387,-0.4133339832045303,-0.04573591482965327,0.04076364243647283,0.3899711526064769,FALSE,FALSE,0.9977264264980498,0.9943046406598173,102.340708701084,16.4696058699851,Hepatoblastoma_histology_II; hepatoblastoma_disease_subtype_I; t_cell_disease_subtype_II; brenner_tumor_disease_subtype_I; T-cell_histology_II,Rhabdomyosarcoma_histology_II; non_hodgkin_lymphoma_disease_subtype_I; DLBCL_disease_subtype_II,0.1316668308659087,Core_omics: [UVSSA_(57654)_RNAseq],NA,NA,0.3060270016792409,Core_omics: [LRP1_(4035)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,15.05,8.4,22.26,4.41,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
79091,METTL22,methyltransferase like 22,0,0,NA,NA,-0.3087063374106322,-3.7098472874543824,NA,NA,0.03439538541937499,0.008553300541698056,-0.18223819875995423,NA,NA,NA,FALSE,NA,0.9829711450692975,NA,40.7816788996547,NA,Oligodendroglioma_histology_II; oligodendroglioma_disease_subtype_II; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,NA,0.06308969076648147,Related: [cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
124512,METTL23,methyltransferase like 23,0.12330009066183137,11,NA,NA,-1.2287851614701664,-5.670250533229135,NA,NA,-0.21654412103405052,0.03186862946086986,-1.056046681282061,NA,NA,NA,FALSE,NA,0.9386014394357926,NA,147.734283564402,NA,peripheral_nervous_system_disease; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I; CLL_disease_subtype_I; haematopoietic_and_lymphoid_tissue_primary_tissue,NA,0.3180112828112976,Core_omics: [SELL_(6402)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,25.17,20.4,4.37,30.63,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
728464,METTL24,methyltransferase like 24,0,0,NA,NA,-0.35954161847487714,-4.383040891428582,NA,NA,-0.024393175952322904,0.005846869036315473,-0.18598619772767802,NA,NA,NA,FALSE,NA,0.9928497122040085,NA,77.8816396640736,NA,mixed_germ_cell_disease_subtype_I; Astrocytoma_histology_II; astrocytoma_disease_subtype_II,NA,0.07867271117812134,Core_omics: [PLEKHA2_(59339)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84190,METTL25,methyltransferase like 25,0.009972801450589302,0,NA,NA,-1.0650142547350052,-8.216392514777315,NA,NA,-0.12184572858365922,0.0131769908090707,-0.9386457954735973,NA,NA,NA,FALSE,NA,0.9967781635955821,NA,140.062256916155,NA,Osteosarcoma_histology_II; osteosarcoma_disease_subtype_I; DDLPS_histology_II; DDLPS_disease_subtype_II; Liposarcoma_histology_I; liposarcoma_disease_subtype_I,NA,0.2312285416970518,Core_omics: [OR2S2_(56656)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,TRUE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,0.4,84,0.98,0.94,0.9,0.9,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84326,METTL26,methyltransferase like 26,9.066183136899365e-4,0,NA,NA,-0.4507632111295247,-4.145159002064022,NA,NA,-0.022532942662256656,0.01067265164041467,-0.4687348063795819,NA,NA,NA,FALSE,NA,0.9917887482634994,NA,57.0854930647781,NA,bone_disease; rhabdomyosarcoma_disease_subtype_I; t_cell_disease_subtype_II; bone_primary_tissue; Chordoma_histology_II; chordoma_disease_subtype_I,NA,0.3423526090469871,Related: [cas9_activity_crispr_confounders; cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
155368,METTL27,methyltransferase like 27,0,0,NA,NA,-0.5067993704225378,-4.676287679321249,NA,NA,-0.06031083740396685,0.009116290962449435,-0.1813223748596625,NA,NA,NA,FALSE,NA,0.9917730056858899,NA,42.2004938582368,NA,Lymphoma_histology_I; lymphocyte_disease; non_hodgkin_lymphoma_disease_subtype_I; b_cell_burkitt_disease_subtype_II; haematopoietic_and_lymphoid_tissue_primary_tissue,NA,0.25441831040530644,Related: [cell_line_NNMD_crispr_confounders; METTL27_(155368)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-3,59,4.12,17.68,12.52,29.52,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
92312,MEX3A,mex-3 RNA binding family member A,0.20126926563916592,4,NA,NA,-0.906309724757042,-3.649671920720603,NA,NA,-0.28042841724132817,0.029408732686934475,-0.3370296006028371,NA,NA,NA,FALSE,NA,0.9615654126790585,NA,29.1863906202996,NA,endometrial_adenocarcinoma_disease_subtype_I; endometrium_primary_tissue; Myeloma_histology_I; plasma_cell_disease; multiple_myeloma_disease_subtype_I,NA,0.27471728564937825,Related: [cell_line_NNMD_crispr_confounders],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
84206,MEX3B,mex-3 RNA binding family member B,0.003626473254759746,0,0,0,-0.5232587380171737,-4.103596924518534,-0.547905655457981,-3.2372634368344877,-0.0696816763713114,0.012217230710382894,-0.06746753493276136,-0.09691099934418498,0.019408264735334385,0.33672114606645076,FALSE,FALSE,0.9930839253674917,0.9866343425584361,69.2183308517917,11.7436100609118,M7_disease_subtype_II; ATL_histology_II; ATL_disease_subtype_I; fibroblast_primary_tissue; Fibroblast_histology_I; fibroblast_disease; fibroblast_soft_tissue_disease_subtype_I,alveolar_disease_subtype_II,0.13403066997437543,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.1579977192277076,Core_omics: [TUBGCP3_(10426)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,50.03,46.92,47.73,50.57,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
51320,MEX3C,mex-3 RNA binding family member C,0,0,0,0,-0.3538153911212506,-3.8027594875877164,-0.71014658518398,-4.5265911182682235,0.03951622725892478,0.01069842880692995,0.11984778492931145,0.08437258455626222,0.030808193000543528,-0.34862244429802625,FALSE,FALSE,0.7276137069461732,0.99168216655617,48.6149476672176,32.3405349366482,Splenic_histology_II; splenic_lymphoma_disease_subtype_II; abdomen_primary_tissue; b_cell_primary_effusion_disease_subtype_II; Lymphoma_histology_I; lymphocyte_disease,endometrial_stromal_sarcoma_disease_subtype_I; mixed_endometrioid_clear_cell_disease_subtype_II; AML_disease_subtype_I; Leukemia_histology_I; blood_disease,0.14376722632509517,Related: [cell_line_NNMD_crispr_confounders],NA,NA,0.1930240512087147,Core_omics: [TENT5A_(55603)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,0,0,0,0,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
399664,MEX3D,mex-3 RNA binding family member D,0,0,0.0018281535648994515,0,-0.36090221023554936,-4.817451098371256,-0.603450739485111,-3.0298728953774514,0.047311859739729935,0.007180278828853868,-0.23542425815601215,-0.04911909945540933,0.033472682314927185,0.18833399091063827,FALSE,FALSE,0.9972067088197601,0.982513344497607,17.9984009799405,6.05630255780261,M3_disease_subtype_II; AML_disease_subtype_I; Leukemia_histology_I; blood_disease; soft_tissue_disease,skin_disease; pleura_primary_tissue; melanoma_disease_subtype_I; Melanoma_histology_II; Medulloblastoma_histology_II; medulloblastoma_disease_subtype_I,0.29997618165112766,Core_omics: [SQOR_(58472)_RNAseq],NA,NA,0.23878300495554655,Core_omics: [CIPC_(85457)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,FALSE,-3,59,69.78,51.11,78.14,37.03,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
4893,NRAS,"NRAS proto-oncogene, GTPase",0.08884859474161379,44,0.042134831460674156,19,-1.977983006360388,-6.693478244081131,-1.99674878566424,-6.346948266185532,-0.22132875343681868,0.06887615119113877,-3.3066144469000087,-0.08170829301230446,0.09103869127593614,-2.7554816640341793,FALSE,FALSE,0.9642339678285603,0.8683255784318172,1067.69586356575,611.207475356596,Meningioma_histology_II; meningioma_disease_subtype_I; M5_disease_subtype_II; melanoma_disease_subtype_I; Fibrosarcoma_histology_II; fibrosarcoma_disease_subtype_I,haematopoietic_and_lymphoid_tissue_primary_tissue; Fibrosarcoma_histology_II; fibrosarcoma_disease_subtype_I; Leukemia_histology_I; blood_disease,0.7845981204621905,Related: [NRAS_(4893)_MutHot],Core_omics: [NRAS_(4893)_MutHot] | DNA_based: [NRAS_(4893)_MutHot],NA,0.7001736380858172,Related: [NRAS_(4893)_MutHot; NRAS_(4893)_MutDrv],Core_omics: [NRAS_(4893)_MutHot] | DNA_based: [NRAS_(4893)_MutHot],NA,TRUE,Gain-of-function,TRUE,Gain-of-function,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,-0.1,78,71.14,79.19,71.05,90.07,FALSE,FALSE,FALSE,lonafarnib,TRUE,0,Biological Testing,TRUE,TRUE,TRUE
5676,PSG7,pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene),NA,NA,0,0,NA,NA,-0.410715486359839,-3.3088225621531255,NA,NA,NA,-0.013181327552135967,0.014434506728678208,0.13581191779665192,NA,FALSE,NA,0.995691515021726,NA,8.11082440239863,NA,Rhabdomyosarcoma_histology_II; engineered_prostate_disease; prostate_primary_tissue; uvea_primary_tissue; papillary_disease_subtype_II,NA,NA,NA,NA,0.1262001040757086,Core_omics: [SPARCL1_(8404)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-0.95,69,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
6663,SOX10,SRY-box transcription factor 10,0.11967361740707162,64,0.04507042253521127,17,-1.779714966327257,-5.277379600539458,-1.63058368301019,-6.57603699141459,-0.2852683430252837,0.08019072652689373,-2.772179801922885,-0.00626109215935235,0.06101211411314022,-2.8462896272831233,FALSE,FALSE,0.991595575637711,0.9717897298982293,1024.02597087321,634.426465211396,melanoma_disease_subtype_I; Melanoma_histology_II; skin_disease; skin_primary_tissue; amelanotic_disease_subtype_II,melanoma_disease_subtype_I; skin_disease; Melanoma_histology_II; skin_primary_tissue; amelanotic_disease_subtype_II,0.8425524711834526,Related: [SOX10_(6663)_RNAseq],Core_omics: [SOX10_(6663)_RNAseq] | DNA_based: [melanoma_Lin],NA,0.83467850682408,Related: [SOX10_(6663)_RNAseq],Core_omics: [SOX10_(6663)_RNAseq] | DNA_based: [melanoma_Lin; skin_Lin],NA,TRUE,Copy Number,TRUE,Copy Number,TRUE,Non-Essential Tissue,TRUE,Non-Essential Tissue,TRUE,BRAF (new),NA,TRUE,BRAF (new),NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,FALSE,TRUE,-3,59,75.26,88.36,50.75,93.84,FALSE,TRUE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
11092,SPACA9,sperm acrosome associated 9,0,0,NA,NA,-0.3881425720015952,-3.6846236630774287,NA,NA,-0.040209430302977245,0.008916723987036402,-0.11355069189921518,NA,NA,NA,FALSE,NA,0.9944938582826985,NA,20.6946288505887,NA,embryo_carcinoma_disease_subtype_I; Neuroblastoma_histology_I; neuroblastoma_disease_subtype_I,NA,0.05491393592734906,DNA_based: [KAT6A_(7994)_CN],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,FALSE,TRUE,FALSE,-3,59,21.69,62.14,14.78,54.3,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
23371,TNS2,tensin 2,0.030825022665457842,0,0.005649717514124294,1,-0.6267204358431253,-3.8473411186364093,-0.979462430798232,-5.187732166015529,-0.18763632502049749,0.013024889721495578,-0.3113337924614658,0.01773386933383867,0.03694930082007697,-0.47503697428847225,FALSE,FALSE,0.8612170188503601,0.9899450819644152,50.3045193309806,63.7752091010702,breast_primary_tissue; mucinous_disease_subtype_II; breast_disease,cervix_primary_tissue; cervical_carcinoma_disease_subtype_I; cervix_disease; Melanoma_histology_II; melanoma_disease_subtype_I,0.34532038697363066,Core_omics: [cell_line_NNMD_crispr_confounders],NA,NA,0.08075325345488275,Core_omics: [AIG1_(51390)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,-1.95,59,78.1,91.16,91.13,86.2,FALSE,FALSE,FALSE,NA,FALSE,NA,NA,FALSE,FALSE,FALSE
9865,TRIL,TLR4 interactor with leucine rich repeats,NA,NA,0,0,NA,NA,-0.509787879580295,-3.4195592406308384,NA,NA,NA,-0.052378500852606515,0.01789245223583943,0.11591084777583655,NA,FALSE,NA,0.993531335943268,NA,32.7635273396171,NA,caecum_adenocarcinoma_disease_subtype_I,NA,NA,NA,NA,0.24754185480466986,Core_omics: [RASSF5_(83593)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,TRUE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,-0.05,79,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
81622,UNC93B1,"unc-93 homolog B1, TLR signaling regulator",NA,NA,0,0,NA,NA,-0.462759822861014,-3.920257399290921,NA,NA,NA,0.029035754746840333,0.015737656858867327,0.049058097191874706,NA,FALSE,NA,0.8911207873916119,NA,6.4188978444493,NA,tubular_disease_subtype_II; stomach_primary_tissue; kidney_disease; kidney_primary_tissue; renal_cell_carcinoma_disease_subtype_I,NA,NA,NA,NA,0.19958026005746643,Core_omics: [PLEKHO1_(51177)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,FALSE,FALSE,TRUE,TRUE,TRUE,-1.35,65,50.12,19.3,50.35,18.25,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
7791,ZYX,zyxin,0.001813236627379873,0,0.009859154929577466,1,-0.496816575682234,-4.549334505493712,-1.0926341289481,-5.022383263834989,-0.02095193327866139,0.010941355579935341,-0.5779120379922805,-0.03624321349879314,0.04424147657493071,-0.36164246121681876,FALSE,FALSE,0.9716731235101079,0.8950102771909612,92.0253246143782,30.3163914140071,renal_leiomyoblastoma_disease_subtype_II; malignant_rhabdoid_tumor_disease_subtype_I; engineered_disease; MMMT_disease_subtype_I; kidney_primary_tissue,Neuroblastoma_histology_I; peripheral_nervous_system_disease; neuroblastoma_disease_subtype_I; autonomic_ganglia_primary_tissue; plasmacytoma_disease_subtype_II,0.3226058543349675,Core_omics: [VIM_(7431)_RNAseq],NA,NA,0.17607734180012027,Related: [ABLIM3_(22885)_RNAseq],NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,FALSE,TRUE,TRUE,FALSE,TRUE,FALSE,FALSE,-3,59,61.52,81.75,52.92,87.81,FALSE,FALSE,FALSE,NA,FALSE,0,NA,FALSE,FALSE,FALSE
